<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_neg 1439146504567 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CUI_TCF21_TARGETS_2_DN'>CUI_TCF21_TARGETS_2_DN</a></td><td><a href='CUI_TCF21_TARGETS_2_DN.html'>Details ...</a></td><td>677</td><td>-0.18</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2444</td><td>tags=26%, list=20%, signal=31%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES'>BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES</a></td><td><a href='BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES.html'>Details ...</a></td><td>61</td><td>-0.53</td><td>-2.20</td><td>0.000</td><td>0.007</td><td>0.018</td><td>3418</td><td>tags=67%, list=28%, signal=93%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN'>CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN</a></td><td><a href='CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN.html'>Details ...</a></td><td>19</td><td>-0.73</td><td>-2.19</td><td>0.000</td><td>0.006</td><td>0.024</td><td>2323</td><td>tags=74%, list=19%, signal=91%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_7P15_AMPLICON'>NIKOLSKY_BREAST_CANCER_7P15_AMPLICON</a></td><td><a href='NIKOLSKY_BREAST_CANCER_7P15_AMPLICON.html'>Details ...</a></td><td>11</td><td>-0.79</td><td>-2.06</td><td>0.000</td><td>0.023</td><td>0.115</td><td>1737</td><td>tags=73%, list=14%, signal=85%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_HCP_WITH_H3K27ME3'>MIKKELSEN_ES_HCP_WITH_H3K27ME3</a></td><td><a href='MIKKELSEN_ES_HCP_WITH_H3K27ME3.html'>Details ...</a></td><td>27</td><td>-0.59</td><td>-2.04</td><td>0.000</td><td>0.024</td><td>0.146</td><td>1567</td><td>tags=44%, list=13%, signal=51%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_ADIPOGENIC_POTENTIAL_DN'>TSENG_ADIPOGENIC_POTENTIAL_DN</a></td><td><a href='TSENG_ADIPOGENIC_POTENTIAL_DN.html'>Details ...</a></td><td>43</td><td>-0.53</td><td>-2.04</td><td>0.000</td><td>0.020</td><td>0.148</td><td>2181</td><td>tags=47%, list=18%, signal=57%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_UP'>HAHTOLA_MYCOSIS_FUNGOIDES_UP</a></td><td><a href='HAHTOLA_MYCOSIS_FUNGOIDES_UP.html'>Details ...</a></td><td>13</td><td>-0.64</td><td>-1.82</td><td>0.012</td><td>0.211</td><td>0.850</td><td>2180</td><td>tags=54%, list=18%, signal=66%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP'>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP</a></td><td><a href='CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP.html'>Details ...</a></td><td>45</td><td>-0.47</td><td>-1.81</td><td>0.006</td><td>0.195</td><td>0.864</td><td>3325</td><td>tags=58%, list=27%, signal=79%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MOREIRA_RESPONSE_TO_TSA_DN'>MOREIRA_RESPONSE_TO_TSA_DN</a></td><td><a href='MOREIRA_RESPONSE_TO_TSA_DN.html'>Details ...</a></td><td>17</td><td>-0.59</td><td>-1.76</td><td>0.007</td><td>0.263</td><td>0.955</td><td>499</td><td>tags=24%, list=4%, signal=25%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SEKI_INFLAMMATORY_RESPONSE_LPS_DN'>SEKI_INFLAMMATORY_RESPONSE_LPS_DN</a></td><td><a href='SEKI_INFLAMMATORY_RESPONSE_LPS_DN.html'>Details ...</a></td><td>23</td><td>-0.52</td><td>-1.70</td><td>0.023</td><td>0.389</td><td>0.995</td><td>2555</td><td>tags=48%, list=21%, signal=60%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_SEMINOMA_DN'>KORKOLA_SEMINOMA_DN</a></td><td><a href='KORKOLA_SEMINOMA_DN.html'>Details ...</a></td><td>10</td><td>-0.66</td><td>-1.68</td><td>0.012</td><td>0.409</td><td>0.998</td><td>3445</td><td>tags=70%, list=28%, signal=98%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TROGLITAZONE_DN'>RUAN_RESPONSE_TO_TROGLITAZONE_DN</a></td><td><a href='RUAN_RESPONSE_TO_TROGLITAZONE_DN.html'>Details ...</a></td><td>18</td><td>-0.53</td><td>-1.65</td><td>0.021</td><td>0.473</td><td>1.000</td><td>1005</td><td>tags=39%, list=8%, signal=42%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_EMBRYONAL_CARCINOMA_DN'>KORKOLA_EMBRYONAL_CARCINOMA_DN</a></td><td><a href='KORKOLA_EMBRYONAL_CARCINOMA_DN.html'>Details ...</a></td><td>10</td><td>-0.66</td><td>-1.65</td><td>0.021</td><td>0.443</td><td>1.000</td><td>3445</td><td>tags=70%, list=28%, signal=98%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HEDENFALK_BREAST_CANCER_BRACX_DN'>HEDENFALK_BREAST_CANCER_BRACX_DN</a></td><td><a href='HEDENFALK_BREAST_CANCER_BRACX_DN.html'>Details ...</a></td><td>17</td><td>-0.55</td><td>-1.64</td><td>0.013</td><td>0.420</td><td>1.000</td><td>3202</td><td>tags=53%, list=26%, signal=72%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP'>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP</a></td><td><a href='FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP.html'>Details ...</a></td><td>47</td><td>-0.41</td><td>-1.64</td><td>0.005</td><td>0.414</td><td>1.000</td><td>3780</td><td>tags=60%, list=31%, signal=86%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_CREB1_TARGETS_DN'>MCCLUNG_CREB1_TARGETS_DN</a></td><td><a href='MCCLUNG_CREB1_TARGETS_DN.html'>Details ...</a></td><td>46</td><td>-0.41</td><td>-1.62</td><td>0.000</td><td>0.443</td><td>1.000</td><td>803</td><td>tags=17%, list=7%, signal=19%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP'>BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP</a></td><td><a href='BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP.html'>Details ...</a></td><td>26</td><td>-0.48</td><td>-1.62</td><td>0.012</td><td>0.420</td><td>1.000</td><td>1711</td><td>tags=31%, list=14%, signal=36%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN'>RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN</a></td><td><a href='RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN.html'>Details ...</a></td><td>40</td><td>-0.42</td><td>-1.60</td><td>0.015</td><td>0.453</td><td>1.000</td><td>1796</td><td>tags=33%, list=15%, signal=38%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/XU_RESPONSE_TO_TRETINOIN_UP'>XU_RESPONSE_TO_TRETINOIN_UP</a></td><td><a href='XU_RESPONSE_TO_TRETINOIN_UP.html'>Details ...</a></td><td>14</td><td>-0.56</td><td>-1.59</td><td>0.022</td><td>0.444</td><td>1.000</td><td>660</td><td>tags=36%, list=5%, signal=38%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_CITED1_TARGETS_1_UP'>HOWLIN_CITED1_TARGETS_1_UP</a></td><td><a href='HOWLIN_CITED1_TARGETS_1_UP.html'>Details ...</a></td><td>24</td><td>-0.45</td><td>-1.51</td><td>0.036</td><td>0.705</td><td>1.000</td><td>3874</td><td>tags=58%, list=32%, signal=86%</td></tr><tr><td class='lessen'>21</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_RESPONSE_TRANSLATION'>BILANGES_SERUM_RESPONSE_TRANSLATION</a></td><td><a href='BILANGES_SERUM_RESPONSE_TRANSLATION.html'>Details ...</a></td><td>30</td><td>-0.42</td><td>-1.48</td><td>0.052</td><td>0.778</td><td>1.000</td><td>1841</td><td>tags=37%, list=15%, signal=43%</td></tr><tr><td class='lessen'>22</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP'>RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP</a></td><td><a href='RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP.html'>Details ...</a></td><td>15</td><td>-0.51</td><td>-1.48</td><td>0.083</td><td>0.765</td><td>1.000</td><td>3943</td><td>tags=73%, list=33%, signal=109%</td></tr><tr><td class='lessen'>23</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/PIEPOLI_LGI1_TARGETS_UP'>PIEPOLI_LGI1_TARGETS_UP</a></td><td><a href='PIEPOLI_LGI1_TARGETS_UP.html'>Details ...</a></td><td>13</td><td>-0.53</td><td>-1.48</td><td>0.062</td><td>0.736</td><td>1.000</td><td>655</td><td>tags=31%, list=5%, signal=32%</td></tr><tr><td class='lessen'>24</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_ICP_WITH_H3K27ME3'>MIKKELSEN_IPS_ICP_WITH_H3K27ME3</a></td><td><a href='MIKKELSEN_IPS_ICP_WITH_H3K27ME3.html'>Details ...</a></td><td>40</td><td>-0.39</td><td>-1.46</td><td>0.015</td><td>0.783</td><td>1.000</td><td>781</td><td>tags=25%, list=6%, signal=27%</td></tr><tr><td class='lessen'>25</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SU_KIDNEY'>SU_KIDNEY</a></td><td><a href='SU_KIDNEY.html'>Details ...</a></td><td>12</td><td>-0.55</td><td>-1.46</td><td>0.075</td><td>0.757</td><td>1.000</td><td>696</td><td>tags=33%, list=6%, signal=35%</td></tr><tr><td class='lessen'>26</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BAE_BRCA1_TARGETS_DN'>BAE_BRCA1_TARGETS_DN</a></td><td><a href='BAE_BRCA1_TARGETS_DN.html'>Details ...</a></td><td>29</td><td>-0.41</td><td>-1.46</td><td>0.070</td><td>0.739</td><td>1.000</td><td>1333</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>27</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN'>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</a></td><td><a href='MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN.html'>Details ...</a></td><td>22</td><td>-0.45</td><td>-1.45</td><td>0.047</td><td>0.749</td><td>1.000</td><td>591</td><td>tags=23%, list=5%, signal=24%</td></tr><tr><td class='lessen'>28</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_LUMINAL_A_UP'>SMID_BREAST_CANCER_LUMINAL_A_UP</a></td><td><a href='SMID_BREAST_CANCER_LUMINAL_A_UP.html'>Details ...</a></td><td>73</td><td>-0.34</td><td>-1.44</td><td>0.023</td><td>0.748</td><td>1.000</td><td>1426</td><td>tags=30%, list=12%, signal=34%</td></tr><tr><td class='lessen'>29</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WONG_ENDMETRIUM_CANCER_DN'>WONG_ENDMETRIUM_CANCER_DN</a></td><td><a href='WONG_ENDMETRIUM_CANCER_DN.html'>Details ...</a></td><td>70</td><td>-0.34</td><td>-1.44</td><td>0.042</td><td>0.727</td><td>1.000</td><td>2026</td><td>tags=37%, list=17%, signal=44%</td></tr><tr><td class='lessen'>30</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_MUSCLE_DN'>LEE_AGING_MUSCLE_DN</a></td><td><a href='LEE_AGING_MUSCLE_DN.html'>Details ...</a></td><td>39</td><td>-0.38</td><td>-1.43</td><td>0.035</td><td>0.736</td><td>1.000</td><td>1253</td><td>tags=21%, list=10%, signal=23%</td></tr><tr><td class='lessen'>31</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/STREICHER_LSM1_TARGETS_DN'>STREICHER_LSM1_TARGETS_DN</a></td><td><a href='STREICHER_LSM1_TARGETS_DN.html'>Details ...</a></td><td>17</td><td>-0.47</td><td>-1.43</td><td>0.067</td><td>0.731</td><td>1.000</td><td>981</td><td>tags=29%, list=8%, signal=32%</td></tr><tr><td class='lessen'>32</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/OLSSON_E2F3_TARGETS_UP'>OLSSON_E2F3_TARGETS_UP</a></td><td><a href='OLSSON_E2F3_TARGETS_UP.html'>Details ...</a></td><td>21</td><td>-0.44</td><td>-1.42</td><td>0.065</td><td>0.746</td><td>1.000</td><td>2716</td><td>tags=48%, list=22%, signal=61%</td></tr><tr><td class='lessen'>33</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP'>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP</a></td><td><a href='BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP.html'>Details ...</a></td><td>26</td><td>-0.41</td><td>-1.41</td><td>0.066</td><td>0.753</td><td>1.000</td><td>2497</td><td>tags=46%, list=21%, signal=58%</td></tr><tr><td class='lessen'>34</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/EHRLICH_ICF_SYNDROM_UP'>EHRLICH_ICF_SYNDROM_UP</a></td><td><a href='EHRLICH_ICF_SYNDROM_UP.html'>Details ...</a></td><td>11</td><td>-0.53</td><td>-1.41</td><td>0.105</td><td>0.742</td><td>1.000</td><td>1684</td><td>tags=36%, list=14%, signal=42%</td></tr><tr><td class='lessen'>35</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_7'>SHIN_B_CELL_LYMPHOMA_CLUSTER_7</a></td><td><a href='SHIN_B_CELL_LYMPHOMA_CLUSTER_7.html'>Details ...</a></td><td>27</td><td>-0.42</td><td>-1.41</td><td>0.046</td><td>0.722</td><td>1.000</td><td>1223</td><td>tags=22%, list=10%, signal=25%</td></tr><tr><td class='lessen'>36</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MOSERLE_IFNA_RESPONSE'>MOSERLE_IFNA_RESPONSE</a></td><td><a href='MOSERLE_IFNA_RESPONSE.html'>Details ...</a></td><td>19</td><td>-0.45</td><td>-1.40</td><td>0.070</td><td>0.716</td><td>1.000</td><td>784</td><td>tags=21%, list=6%, signal=22%</td></tr><tr><td class='lessen'>37</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ITO_PTTG1_TARGETS_UP'>ITO_PTTG1_TARGETS_UP</a></td><td><a href='ITO_PTTG1_TARGETS_UP.html'>Details ...</a></td><td>10</td><td>-0.56</td><td>-1.40</td><td>0.090</td><td>0.704</td><td>1.000</td><td>159</td><td>tags=30%, list=1%, signal=30%</td></tr><tr><td class='lessen'>38</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KANG_AR_TARGETS_UP'>KANG_AR_TARGETS_UP</a></td><td><a href='KANG_AR_TARGETS_UP.html'>Details ...</a></td><td>17</td><td>-0.47</td><td>-1.40</td><td>0.088</td><td>0.697</td><td>1.000</td><td>634</td><td>tags=24%, list=5%, signal=25%</td></tr><tr><td class='lessen'>39</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON'>NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON</a></td><td><a href='NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON.html'>Details ...</a></td><td>30</td><td>-0.39</td><td>-1.39</td><td>0.062</td><td>0.713</td><td>1.000</td><td>172</td><td>tags=13%, list=1%, signal=13%</td></tr><tr><td class='lessen'>40</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/YUAN_ZNF143_PARTNERS'>YUAN_ZNF143_PARTNERS</a></td><td><a href='YUAN_ZNF143_PARTNERS.html'>Details ...</a></td><td>18</td><td>-0.45</td><td>-1.39</td><td>0.079</td><td>0.696</td><td>1.000</td><td>3520</td><td>tags=56%, list=29%, signal=78%</td></tr><tr><td class='lessen'>41</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHOW_RASSF1_TARGETS_DN'>CHOW_RASSF1_TARGETS_DN</a></td><td><a href='CHOW_RASSF1_TARGETS_DN.html'>Details ...</a></td><td>25</td><td>-0.42</td><td>-1.37</td><td>0.086</td><td>0.741</td><td>1.000</td><td>2416</td><td>tags=36%, list=20%, signal=45%</td></tr><tr><td class='lessen'>42</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KANG_IMMORTALIZED_BY_TERT_DN'>KANG_IMMORTALIZED_BY_TERT_DN</a></td><td><a href='KANG_IMMORTALIZED_BY_TERT_DN.html'>Details ...</a></td><td>90</td><td>-0.31</td><td>-1.37</td><td>0.000</td><td>0.724</td><td>1.000</td><td>2016</td><td>tags=39%, list=17%, signal=46%</td></tr><tr><td class='lessen'>43</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DASU_IL6_SIGNALING_SCAR_UP'>DASU_IL6_SIGNALING_SCAR_UP</a></td><td><a href='DASU_IL6_SIGNALING_SCAR_UP.html'>Details ...</a></td><td>27</td><td>-0.40</td><td>-1.37</td><td>0.078</td><td>0.715</td><td>1.000</td><td>577</td><td>tags=26%, list=5%, signal=27%</td></tr><tr><td class='lessen'>44</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DIRMEIER_LMP1_RESPONSE_LATE_DN'>DIRMEIER_LMP1_RESPONSE_LATE_DN</a></td><td><a href='DIRMEIER_LMP1_RESPONSE_LATE_DN.html'>Details ...</a></td><td>28</td><td>-0.40</td><td>-1.37</td><td>0.078</td><td>0.700</td><td>1.000</td><td>2794</td><td>tags=39%, list=23%, signal=51%</td></tr><tr><td class='lessen'>45</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WAKASUGI_HAVE_ZNF143_BINDING_SITES'>WAKASUGI_HAVE_ZNF143_BINDING_SITES</a></td><td><a href='WAKASUGI_HAVE_ZNF143_BINDING_SITES.html'>Details ...</a></td><td>55</td><td>-0.34</td><td>-1.37</td><td>0.037</td><td>0.699</td><td>1.000</td><td>2980</td><td>tags=35%, list=25%, signal=46%</td></tr><tr><td class='lessen'>46</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/FUKUSHIMA_TNFSF11_TARGETS'>FUKUSHIMA_TNFSF11_TARGETS</a></td><td><a href='FUKUSHIMA_TNFSF11_TARGETS.html'>Details ...</a></td><td>13</td><td>-0.48</td><td>-1.37</td><td>0.123</td><td>0.688</td><td>1.000</td><td>3120</td><td>tags=46%, list=26%, signal=62%</td></tr><tr><td class='lessen'>47</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER'>WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER</a></td><td><a href='WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER.html'>Details ...</a></td><td>46</td><td>-0.36</td><td>-1.36</td><td>0.040</td><td>0.690</td><td>1.000</td><td>1701</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>48</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/VERNOCHET_ADIPOGENESIS'>VERNOCHET_ADIPOGENESIS</a></td><td><a href='VERNOCHET_ADIPOGENESIS.html'>Details ...</a></td><td>18</td><td>-0.44</td><td>-1.35</td><td>0.101</td><td>0.715</td><td>1.000</td><td>2292</td><td>tags=50%, list=19%, signal=62%</td></tr><tr><td class='lessen'>49</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN'>DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN</a></td><td><a href='DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN.html'>Details ...</a></td><td>24</td><td>-0.40</td><td>-1.34</td><td>0.096</td><td>0.748</td><td>1.000</td><td>967</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>50</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP'>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</a></td><td><a href='WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP.html'>Details ...</a></td><td>10</td><td>-0.51</td><td>-1.34</td><td>0.160</td><td>0.744</td><td>1.000</td><td>77</td><td>tags=20%, list=1%, signal=20%</td></tr><tr><td class='lessen'>51</td><td>LEE_LIVER_CANCER_MYC_E2F1_DN</td><td></td><td>47</td><td>-0.34</td><td>-1.33</td><td>0.086</td><td>0.747</td><td>1.000</td><td>1896</td><td>tags=30%, list=16%, signal=35%</td></tr><tr><td class='lessen'>52</td><td>ZHAN_MULTIPLE_MYELOMA_PR_DN</td><td></td><td>37</td><td>-0.36</td><td>-1.33</td><td>0.079</td><td>0.736</td><td>1.000</td><td>2972</td><td>tags=43%, list=25%, signal=57%</td></tr><tr><td class='lessen'>53</td><td>NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON</td><td></td><td>94</td><td>-0.29</td><td>-1.33</td><td>0.036</td><td>0.722</td><td>1.000</td><td>1311</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>54</td><td>BALDWIN_PRKCI_TARGETS_UP</td><td></td><td>33</td><td>-0.36</td><td>-1.33</td><td>0.077</td><td>0.720</td><td>1.000</td><td>2498</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>55</td><td>MATZUK_MALE_REPRODUCTION_SERTOLI</td><td></td><td>24</td><td>-0.40</td><td>-1.32</td><td>0.123</td><td>0.716</td><td>1.000</td><td>628</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>56</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_DN</td><td></td><td>61</td><td>-0.32</td><td>-1.31</td><td>0.066</td><td>0.740</td><td>1.000</td><td>3316</td><td>tags=43%, list=27%, signal=58%</td></tr><tr><td class='lessen'>57</td><td>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN</td><td></td><td>16</td><td>-0.43</td><td>-1.30</td><td>0.131</td><td>0.773</td><td>1.000</td><td>2417</td><td>tags=44%, list=20%, signal=55%</td></tr><tr><td class='lessen'>58</td><td>PEDRIOLI_MIR31_TARGETS_UP</td><td></td><td>134</td><td>-0.27</td><td>-1.30</td><td>0.029</td><td>0.767</td><td>1.000</td><td>1454</td><td>tags=25%, list=12%, signal=29%</td></tr><tr><td class='lessen'>59</td><td>MATZUK_OVULATION</td><td></td><td>14</td><td>-0.46</td><td>-1.29</td><td>0.159</td><td>0.783</td><td>1.000</td><td>1635</td><td>tags=57%, list=13%, signal=66%</td></tr><tr><td class='lessen'>60</td><td>WANG_METASTASIS_OF_BREAST_CANCER</td><td></td><td>10</td><td>-0.51</td><td>-1.29</td><td>0.187</td><td>0.774</td><td>1.000</td><td>1732</td><td>tags=40%, list=14%, signal=47%</td></tr><tr><td class='lessen'>61</td><td>BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN</td><td></td><td>42</td><td>-0.34</td><td>-1.29</td><td>0.138</td><td>0.763</td><td>1.000</td><td>2574</td><td>tags=55%, list=21%, signal=69%</td></tr><tr><td class='lessen'>62</td><td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP</td><td></td><td>16</td><td>-0.44</td><td>-1.29</td><td>0.160</td><td>0.753</td><td>1.000</td><td>306</td><td>tags=31%, list=3%, signal=32%</td></tr><tr><td class='lessen'>63</td><td>YANG_MUC2_TARGETS_DUODENUM_6MO_DN</td><td></td><td>14</td><td>-0.45</td><td>-1.29</td><td>0.148</td><td>0.745</td><td>1.000</td><td>2113</td><td>tags=43%, list=17%, signal=52%</td></tr><tr><td class='lessen'>64</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</td><td></td><td>181</td><td>-0.26</td><td>-1.28</td><td>0.000</td><td>0.767</td><td>1.000</td><td>2527</td><td>tags=34%, list=21%, signal=42%</td></tr><tr><td class='lessen'>65</td><td>MATZUK_POST-IMPLANTATION_AND_POST-PARTUM</td><td></td><td>11</td><td>-0.48</td><td>-1.28</td><td>0.156</td><td>0.778</td><td>1.000</td><td>3448</td><td>tags=55%, list=28%, signal=76%</td></tr><tr><td class='lessen'>66</td><td>GENTLES_LEUKEMIC_STEM_CELL_UP</td><td></td><td>22</td><td>-0.39</td><td>-1.27</td><td>0.137</td><td>0.769</td><td>1.000</td><td>3206</td><td>tags=59%, list=26%, signal=80%</td></tr><tr><td class='lessen'>67</td><td>GYORFFY_MITOXANTRONE_RESISTANCE</td><td></td><td>43</td><td>-0.33</td><td>-1.26</td><td>0.108</td><td>0.796</td><td>1.000</td><td>1426</td><td>tags=26%, list=12%, signal=29%</td></tr><tr><td class='lessen'>68</td><td>KRASNOSELSKAYA_ILF3_TARGETS_UP</td><td></td><td>28</td><td>-0.37</td><td>-1.26</td><td>0.152</td><td>0.817</td><td>1.000</td><td>3704</td><td>tags=57%, list=31%, signal=82%</td></tr><tr><td class='lessen'>69</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4</td><td></td><td>13</td><td>-0.43</td><td>-1.25</td><td>0.190</td><td>0.813</td><td>1.000</td><td>1635</td><td>tags=31%, list=13%, signal=36%</td></tr><tr><td class='lessen'>70</td><td>GENTILE_UV_RESPONSE_CLUSTER_D8</td><td></td><td>33</td><td>-0.35</td><td>-1.25</td><td>0.135</td><td>0.809</td><td>1.000</td><td>1597</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>71</td><td>JISON_SICKLE_CELL_DISEASE_DN</td><td></td><td>140</td><td>-0.26</td><td>-1.25</td><td>0.018</td><td>0.800</td><td>1.000</td><td>1921</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>72</td><td>DING_LUNG_CANCER_BY_MUTATION_RATE</td><td></td><td>19</td><td>-0.40</td><td>-1.25</td><td>0.166</td><td>0.795</td><td>1.000</td><td>1661</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>73</td><td>VALK_AML_WITH_FLT3_ITD</td><td></td><td>36</td><td>-0.34</td><td>-1.25</td><td>0.128</td><td>0.795</td><td>1.000</td><td>1728</td><td>tags=39%, list=14%, signal=45%</td></tr><tr><td class='lessen'>74</td><td>CAIRO_HEPATOBLASTOMA_CLASSES_DN</td><td></td><td>164</td><td>-0.26</td><td>-1.24</td><td>0.048</td><td>0.823</td><td>1.000</td><td>2181</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>75</td><td>NIELSEN_LEIOMYOSARCOMA_DN</td><td></td><td>14</td><td>-0.43</td><td>-1.24</td><td>0.162</td><td>0.814</td><td>1.000</td><td>981</td><td>tags=21%, list=8%, signal=23%</td></tr><tr><td class='lessen'>76</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</td><td></td><td>42</td><td>-0.32</td><td>-1.21</td><td>0.115</td><td>0.900</td><td>1.000</td><td>1940</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>77</td><td>NOUZOVA_METHYLATED_IN_APL</td><td></td><td>39</td><td>-0.33</td><td>-1.21</td><td>0.181</td><td>0.901</td><td>1.000</td><td>1022</td><td>tags=21%, list=8%, signal=22%</td></tr><tr><td class='lessen'>78</td><td>MOOTHA_GLUCONEOGENESIS</td><td></td><td>27</td><td>-0.34</td><td>-1.21</td><td>0.175</td><td>0.899</td><td>1.000</td><td>1727</td><td>tags=48%, list=14%, signal=56%</td></tr><tr><td class='lessen'>79</td><td>GYORFFY_DOXORUBICIN_RESISTANCE</td><td></td><td>36</td><td>-0.34</td><td>-1.21</td><td>0.150</td><td>0.892</td><td>1.000</td><td>1455</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>80</td><td>KONDO_PROSTATE_CANCER_WITH_H3K27ME3</td><td></td><td>105</td><td>-0.26</td><td>-1.21</td><td>0.133</td><td>0.884</td><td>1.000</td><td>1878</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>81</td><td>VERHAAK_GLIOBLASTOMA_CLASSICAL</td><td></td><td>133</td><td>-0.25</td><td>-1.21</td><td>0.077</td><td>0.878</td><td>1.000</td><td>1884</td><td>tags=23%, list=16%, signal=26%</td></tr><tr><td class='lessen'>82</td><td>ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN</td><td></td><td>18</td><td>-0.39</td><td>-1.21</td><td>0.233</td><td>0.871</td><td>1.000</td><td>527</td><td>tags=28%, list=4%, signal=29%</td></tr><tr><td class='lessen'>83</td><td>BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE</td><td></td><td>56</td><td>-0.29</td><td>-1.20</td><td>0.148</td><td>0.883</td><td>1.000</td><td>912</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>84</td><td>NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS</td><td></td><td>11</td><td>-0.45</td><td>-1.19</td><td>0.228</td><td>0.900</td><td>1.000</td><td>2675</td><td>tags=45%, list=22%, signal=58%</td></tr><tr><td class='lessen'>85</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN</td><td></td><td>60</td><td>-0.29</td><td>-1.19</td><td>0.127</td><td>0.892</td><td>1.000</td><td>1896</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>86</td><td>NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON</td><td></td><td>12</td><td>-0.45</td><td>-1.19</td><td>0.209</td><td>0.885</td><td>1.000</td><td>2120</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>87</td><td>OXFORD_RALA_OR_RALB_TARGETS_DN</td><td></td><td>18</td><td>-0.40</td><td>-1.19</td><td>0.226</td><td>0.882</td><td>1.000</td><td>2761</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>88</td><td>VALK_AML_CLUSTER_2</td><td></td><td>24</td><td>-0.36</td><td>-1.19</td><td>0.225</td><td>0.876</td><td>1.000</td><td>1144</td><td>tags=29%, list=9%, signal=32%</td></tr><tr><td class='lessen'>89</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_E2</td><td></td><td>27</td><td>-0.35</td><td>-1.19</td><td>0.222</td><td>0.873</td><td>1.000</td><td>1375</td><td>tags=33%, list=11%, signal=38%</td></tr><tr><td class='lessen'>90</td><td>MIKKELSEN_ES_ICP_WITH_H3K27ME3</td><td></td><td>30</td><td>-0.34</td><td>-1.19</td><td>0.200</td><td>0.864</td><td>1.000</td><td>1044</td><td>tags=27%, list=9%, signal=29%</td></tr><tr><td class='lessen'>91</td><td>LEE_LIVER_CANCER_MYC_TGFA_DN</td><td></td><td>49</td><td>-0.30</td><td>-1.19</td><td>0.201</td><td>0.857</td><td>1.000</td><td>1997</td><td>tags=31%, list=16%, signal=36%</td></tr><tr><td class='lessen'>92</td><td>MARZEC_IL2_SIGNALING_DN</td><td></td><td>31</td><td>-0.34</td><td>-1.18</td><td>0.218</td><td>0.857</td><td>1.000</td><td>869</td><td>tags=19%, list=7%, signal=21%</td></tr><tr><td class='lessen'>93</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN</td><td></td><td>12</td><td>-0.43</td><td>-1.18</td><td>0.239</td><td>0.855</td><td>1.000</td><td>338</td><td>tags=17%, list=3%, signal=17%</td></tr><tr><td class='lessen'>94</td><td>VANTVEER_BREAST_CANCER_BRCA1_DN</td><td></td><td>30</td><td>-0.34</td><td>-1.18</td><td>0.203</td><td>0.855</td><td>1.000</td><td>1094</td><td>tags=17%, list=9%, signal=18%</td></tr><tr><td class='lessen'>95</td><td>HUMMERICH_BENIGN_SKIN_TUMOR_DN</td><td></td><td>18</td><td>-0.39</td><td>-1.18</td><td>0.234</td><td>0.857</td><td>1.000</td><td>860</td><td>tags=33%, list=7%, signal=36%</td></tr><tr><td class='lessen'>96</td><td>UEDA_CENTRAL_CLOCK</td><td></td><td>75</td><td>-0.27</td><td>-1.18</td><td>0.158</td><td>0.854</td><td>1.000</td><td>1722</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>97</td><td>MIKKELSEN_IPS_WITH_HCP_H3K27ME3</td><td></td><td>70</td><td>-0.27</td><td>-1.18</td><td>0.178</td><td>0.846</td><td>1.000</td><td>2531</td><td>tags=39%, list=21%, signal=48%</td></tr><tr><td class='lessen'>98</td><td>BROWNE_HCMV_INFECTION_10HR_DN</td><td></td><td>45</td><td>-0.32</td><td>-1.18</td><td>0.227</td><td>0.839</td><td>1.000</td><td>1836</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>99</td><td>FRASOR_TAMOXIFEN_RESPONSE_UP</td><td></td><td>40</td><td>-0.31</td><td>-1.17</td><td>0.186</td><td>0.847</td><td>1.000</td><td>1897</td><td>tags=35%, list=16%, signal=41%</td></tr><tr><td class='lessen'>100</td><td>NUTT_GBM_VS_AO_GLIOMA_UP</td><td></td><td>41</td><td>-0.31</td><td>-1.17</td><td>0.216</td><td>0.863</td><td>1.000</td><td>246</td><td>tags=7%, list=2%, signal=7%</td></tr><tr><td class='lessen'>101</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S2</td><td></td><td>106</td><td>-0.26</td><td>-1.17</td><td>0.135</td><td>0.855</td><td>1.000</td><td>3267</td><td>tags=39%, list=27%, signal=52%</td></tr><tr><td class='lessen'>102</td><td>LEE_LIVER_CANCER_MYC_DN</td><td></td><td>46</td><td>-0.30</td><td>-1.16</td><td>0.186</td><td>0.850</td><td>1.000</td><td>2181</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>103</td><td>VALK_AML_CLUSTER_12</td><td></td><td>28</td><td>-0.34</td><td>-1.16</td><td>0.250</td><td>0.876</td><td>1.000</td><td>655</td><td>tags=18%, list=5%, signal=19%</td></tr><tr><td class='lessen'>104</td><td>CHENG_IMPRINTED_BY_ESTRADIOL</td><td></td><td>80</td><td>-0.27</td><td>-1.15</td><td>0.163</td><td>0.881</td><td>1.000</td><td>1932</td><td>tags=28%, list=16%, signal=32%</td></tr><tr><td class='lessen'>105</td><td>NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON</td><td></td><td>15</td><td>-0.39</td><td>-1.14</td><td>0.256</td><td>0.908</td><td>1.000</td><td>2936</td><td>tags=47%, list=24%, signal=61%</td></tr><tr><td class='lessen'>106</td><td>BILANGES_RAPAMYCIN_SENSITIVE_GENES</td><td></td><td>32</td><td>-0.32</td><td>-1.14</td><td>0.245</td><td>0.900</td><td>1.000</td><td>2835</td><td>tags=34%, list=23%, signal=45%</td></tr><tr><td class='lessen'>107</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>96</td><td>-0.26</td><td>-1.14</td><td>0.146</td><td>0.894</td><td>1.000</td><td>2016</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>108</td><td>RUAN_RESPONSE_TO_TNF_DN</td><td></td><td>79</td><td>-0.27</td><td>-1.14</td><td>0.202</td><td>0.901</td><td>1.000</td><td>1896</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>109</td><td>SAGIV_CD24_TARGETS_UP</td><td></td><td>22</td><td>-0.35</td><td>-1.14</td><td>0.281</td><td>0.895</td><td>1.000</td><td>3542</td><td>tags=64%, list=29%, signal=90%</td></tr><tr><td class='lessen'>110</td><td>ZWANG_EGF_INTERVAL_DN</td><td></td><td>158</td><td>-0.24</td><td>-1.14</td><td>0.117</td><td>0.888</td><td>1.000</td><td>1549</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>111</td><td>SANA_RESPONSE_TO_IFNG_UP</td><td></td><td>45</td><td>-0.29</td><td>-1.13</td><td>0.245</td><td>0.899</td><td>1.000</td><td>3187</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>112</td><td>GRESHOCK_CANCER_COPY_NUMBER_UP</td><td></td><td>291</td><td>-0.22</td><td>-1.13</td><td>0.077</td><td>0.891</td><td>1.000</td><td>3597</td><td>tags=40%, list=30%, signal=56%</td></tr><tr><td class='lessen'>113</td><td>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN</td><td></td><td>43</td><td>-0.30</td><td>-1.13</td><td>0.216</td><td>0.885</td><td>1.000</td><td>339</td><td>tags=9%, list=3%, signal=10%</td></tr><tr><td class='lessen'>114</td><td>PARK_TRETINOIN_RESPONSE</td><td></td><td>12</td><td>-0.42</td><td>-1.13</td><td>0.290</td><td>0.897</td><td>1.000</td><td>49</td><td>tags=17%, list=0%, signal=17%</td></tr><tr><td class='lessen'>115</td><td>LEONARD_HYPOXIA</td><td></td><td>37</td><td>-0.31</td><td>-1.13</td><td>0.265</td><td>0.898</td><td>1.000</td><td>982</td><td>tags=24%, list=8%, signal=26%</td></tr><tr><td class='lessen'>116</td><td>TSUDA_ALVEOLAR_SOFT_PART_SARCOMA</td><td></td><td>10</td><td>-0.43</td><td>-1.12</td><td>0.325</td><td>0.897</td><td>1.000</td><td>410</td><td>tags=20%, list=3%, signal=21%</td></tr><tr><td class='lessen'>117</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP</td><td></td><td>135</td><td>-0.24</td><td>-1.12</td><td>0.172</td><td>0.889</td><td>1.000</td><td>3211</td><td>tags=39%, list=26%, signal=52%</td></tr><tr><td class='lessen'>118</td><td>LEE_LIVER_CANCER_E2F1_DN</td><td></td><td>47</td><td>-0.29</td><td>-1.12</td><td>0.229</td><td>0.897</td><td>1.000</td><td>1760</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>119</td><td>KIM_GERMINAL_CENTER_T_HELPER_DN</td><td></td><td>16</td><td>-0.39</td><td>-1.12</td><td>0.274</td><td>0.890</td><td>1.000</td><td>2110</td><td>tags=31%, list=17%, signal=38%</td></tr><tr><td class='lessen'>120</td><td>COLLIS_PRKDC_SUBSTRATES</td><td></td><td>18</td><td>-0.37</td><td>-1.12</td><td>0.302</td><td>0.889</td><td>1.000</td><td>3458</td><td>tags=50%, list=29%, signal=70%</td></tr><tr><td class='lessen'>121</td><td>IRITANI_MAD1_TARGETS_UP</td><td></td><td>11</td><td>-0.43</td><td>-1.12</td><td>0.304</td><td>0.890</td><td>1.000</td><td>700</td><td>tags=18%, list=6%, signal=19%</td></tr><tr><td class='lessen'>122</td><td>TRAYNOR_RETT_SYNDROM_DN</td><td></td><td>14</td><td>-0.39</td><td>-1.12</td><td>0.311</td><td>0.887</td><td>1.000</td><td>43</td><td>tags=14%, list=0%, signal=14%</td></tr><tr><td class='lessen'>123</td><td>EINAV_INTERFERON_SIGNATURE_IN_CANCER</td><td></td><td>20</td><td>-0.35</td><td>-1.12</td><td>0.276</td><td>0.881</td><td>1.000</td><td>2333</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>124</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_UP</td><td></td><td>55</td><td>-0.27</td><td>-1.11</td><td>0.266</td><td>0.897</td><td>1.000</td><td>2225</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>125</td><td>NAKAYAMA_FGF2_TARGETS</td><td></td><td>24</td><td>-0.34</td><td>-1.11</td><td>0.309</td><td>0.890</td><td>1.000</td><td>205</td><td>tags=13%, list=2%, signal=13%</td></tr><tr><td class='lessen'>126</td><td>HORIUCHI_WTAP_TARGETS_UP</td><td></td><td>232</td><td>-0.22</td><td>-1.11</td><td>0.148</td><td>0.895</td><td>1.000</td><td>1690</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>127</td><td>HAHTOLA_CTCL_PATHOGENESIS</td><td></td><td>13</td><td>-0.39</td><td>-1.11</td><td>0.323</td><td>0.891</td><td>1.000</td><td>1589</td><td>tags=31%, list=13%, signal=35%</td></tr><tr><td class='lessen'>128</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>284</td><td>-0.21</td><td>-1.10</td><td>0.167</td><td>0.903</td><td>1.000</td><td>3660</td><td>tags=42%, list=30%, signal=59%</td></tr><tr><td class='lessen'>129</td><td>LU_TUMOR_VASCULATURE_DN</td><td></td><td>12</td><td>-0.40</td><td>-1.10</td><td>0.313</td><td>0.897</td><td>1.000</td><td>1362</td><td>tags=42%, list=11%, signal=47%</td></tr><tr><td class='lessen'>130</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN</td><td></td><td>48</td><td>-0.28</td><td>-1.10</td><td>0.233</td><td>0.894</td><td>1.000</td><td>3370</td><td>tags=40%, list=28%, signal=55%</td></tr><tr><td class='lessen'>131</td><td>LANDIS_ERBB2_BREAST_TUMORS_65_DN</td><td></td><td>34</td><td>-0.30</td><td>-1.10</td><td>0.315</td><td>0.898</td><td>1.000</td><td>2768</td><td>tags=35%, list=23%, signal=46%</td></tr><tr><td class='lessen'>132</td><td>YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP</td><td></td><td>70</td><td>-0.26</td><td>-1.10</td><td>0.254</td><td>0.892</td><td>1.000</td><td>1753</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>133</td><td>YANG_BREAST_CANCER_ESR1_DN</td><td></td><td>23</td><td>-0.33</td><td>-1.10</td><td>0.299</td><td>0.886</td><td>1.000</td><td>2204</td><td>tags=52%, list=18%, signal=64%</td></tr><tr><td class='lessen'>134</td><td>WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN</td><td></td><td>23</td><td>-0.33</td><td>-1.10</td><td>0.326</td><td>0.882</td><td>1.000</td><td>2353</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>135</td><td>LI_WILMS_TUMOR</td><td></td><td>23</td><td>-0.34</td><td>-1.09</td><td>0.320</td><td>0.907</td><td>1.000</td><td>3712</td><td>tags=61%, list=31%, signal=88%</td></tr><tr><td class='lessen'>136</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP</td><td></td><td>57</td><td>-0.27</td><td>-1.09</td><td>0.303</td><td>0.909</td><td>1.000</td><td>3517</td><td>tags=37%, list=29%, signal=52%</td></tr><tr><td class='lessen'>137</td><td>MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>26</td><td>-0.32</td><td>-1.08</td><td>0.324</td><td>0.908</td><td>1.000</td><td>1064</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>138</td><td>DUAN_PRDM5_TARGETS</td><td></td><td>61</td><td>-0.27</td><td>-1.08</td><td>0.268</td><td>0.902</td><td>1.000</td><td>911</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>139</td><td>DAZARD_RESPONSE_TO_UV_NHEK_DN</td><td></td><td>249</td><td>-0.22</td><td>-1.08</td><td>0.273</td><td>0.901</td><td>1.000</td><td>3063</td><td>tags=36%, list=25%, signal=47%</td></tr><tr><td class='lessen'>140</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22</td><td></td><td>10</td><td>-0.43</td><td>-1.08</td><td>0.374</td><td>0.900</td><td>1.000</td><td>1405</td><td>tags=40%, list=12%, signal=45%</td></tr><tr><td class='lessen'>141</td><td>KYNG_WERNER_SYNDROM_DN</td><td></td><td>18</td><td>-0.35</td><td>-1.08</td><td>0.346</td><td>0.899</td><td>1.000</td><td>3881</td><td>tags=39%, list=32%, signal=57%</td></tr><tr><td class='lessen'>142</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN</td><td></td><td>46</td><td>-0.28</td><td>-1.08</td><td>0.297</td><td>0.901</td><td>1.000</td><td>2514</td><td>tags=33%, list=21%, signal=41%</td></tr><tr><td class='lessen'>143</td><td>RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP</td><td></td><td>14</td><td>-0.37</td><td>-1.08</td><td>0.369</td><td>0.907</td><td>1.000</td><td>2573</td><td>tags=50%, list=21%, signal=63%</td></tr><tr><td class='lessen'>144</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_DN</td><td></td><td>69</td><td>-0.25</td><td>-1.07</td><td>0.280</td><td>0.907</td><td>1.000</td><td>1249</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>145</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8</td><td></td><td>12</td><td>-0.39</td><td>-1.07</td><td>0.380</td><td>0.905</td><td>1.000</td><td>2573</td><td>tags=58%, list=21%, signal=74%</td></tr><tr><td class='lessen'>146</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23</td><td></td><td>17</td><td>-0.36</td><td>-1.07</td><td>0.366</td><td>0.902</td><td>1.000</td><td>2886</td><td>tags=47%, list=24%, signal=62%</td></tr><tr><td class='lessen'>147</td><td>RICKMAN_HEAD_AND_NECK_CANCER_D</td><td></td><td>17</td><td>-0.36</td><td>-1.07</td><td>0.349</td><td>0.903</td><td>1.000</td><td>1706</td><td>tags=41%, list=14%, signal=48%</td></tr><tr><td class='lessen'>148</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM</td><td></td><td>24</td><td>-0.33</td><td>-1.07</td><td>0.346</td><td>0.897</td><td>1.000</td><td>2254</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>149</td><td>BROWNE_HCMV_INFECTION_30MIN_DN</td><td></td><td>105</td><td>-0.23</td><td>-1.07</td><td>0.298</td><td>0.906</td><td>1.000</td><td>1221</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>150</td><td>MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>31</td><td>-0.30</td><td>-1.06</td><td>0.336</td><td>0.913</td><td>1.000</td><td>1074</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>151</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_1_DN</td><td></td><td>33</td><td>-0.29</td><td>-1.06</td><td>0.364</td><td>0.912</td><td>1.000</td><td>2098</td><td>tags=30%, list=17%, signal=37%</td></tr><tr><td class='lessen'>152</td><td>MOOTHA_GLYCOLYSIS</td><td></td><td>19</td><td>-0.35</td><td>-1.06</td><td>0.352</td><td>0.909</td><td>1.000</td><td>2247</td><td>tags=58%, list=19%, signal=71%</td></tr><tr><td class='lessen'>153</td><td>INGRAM_SHH_TARGETS_UP</td><td></td><td>105</td><td>-0.23</td><td>-1.06</td><td>0.288</td><td>0.908</td><td>1.000</td><td>1253</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>154</td><td>LEE_AGING_CEREBELLUM_DN</td><td></td><td>71</td><td>-0.25</td><td>-1.06</td><td>0.341</td><td>0.906</td><td>1.000</td><td>1919</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>155</td><td>NIELSEN_LEIOMYOSARCOMA_CNN1_DN</td><td></td><td>18</td><td>-0.35</td><td>-1.06</td><td>0.386</td><td>0.904</td><td>1.000</td><td>427</td><td>tags=17%, list=4%, signal=17%</td></tr><tr><td class='lessen'>156</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P2</td><td></td><td>60</td><td>-0.26</td><td>-1.06</td><td>0.325</td><td>0.903</td><td>1.000</td><td>1904</td><td>tags=30%, list=16%, signal=35%</td></tr><tr><td class='lessen'>157</td><td>HEDENFALK_BREAST_CANCER_BRACX_UP</td><td></td><td>16</td><td>-0.36</td><td>-1.05</td><td>0.382</td><td>0.912</td><td>1.000</td><td>1862</td><td>tags=31%, list=15%, signal=37%</td></tr><tr><td class='lessen'>158</td><td>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN</td><td></td><td>28</td><td>-0.30</td><td>-1.05</td><td>0.370</td><td>0.914</td><td>1.000</td><td>1770</td><td>tags=39%, list=15%, signal=46%</td></tr><tr><td class='lessen'>159</td><td>HUMMERICH_MALIGNANT_SKIN_TUMOR_DN</td><td></td><td>15</td><td>-0.36</td><td>-1.05</td><td>0.387</td><td>0.912</td><td>1.000</td><td>860</td><td>tags=33%, list=7%, signal=36%</td></tr><tr><td class='lessen'>160</td><td>NADERI_BREAST_CANCER_PROGNOSIS_DN</td><td></td><td>16</td><td>-0.36</td><td>-1.05</td><td>0.382</td><td>0.920</td><td>1.000</td><td>1577</td><td>tags=44%, list=13%, signal=50%</td></tr><tr><td class='lessen'>161</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</td><td></td><td>109</td><td>-0.22</td><td>-1.04</td><td>0.390</td><td>0.922</td><td>1.000</td><td>3032</td><td>tags=37%, list=25%, signal=48%</td></tr><tr><td class='lessen'>162</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_DN</td><td></td><td>54</td><td>-0.26</td><td>-1.04</td><td>0.392</td><td>0.924</td><td>1.000</td><td>1522</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>163</td><td>NAKAMURA_METASTASIS_MODEL_DN</td><td></td><td>34</td><td>-0.28</td><td>-1.04</td><td>0.385</td><td>0.939</td><td>1.000</td><td>1309</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>164</td><td>RODRIGUES_NTN1_TARGETS_UP</td><td></td><td>13</td><td>-0.37</td><td>-1.04</td><td>0.429</td><td>0.935</td><td>1.000</td><td>1522</td><td>tags=31%, list=13%, signal=35%</td></tr><tr><td class='lessen'>165</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL</td><td></td><td>14</td><td>-0.35</td><td>-1.04</td><td>0.383</td><td>0.932</td><td>1.000</td><td>3354</td><td>tags=43%, list=28%, signal=59%</td></tr><tr><td class='lessen'>166</td><td>ROETH_TERT_TARGETS_UP</td><td></td><td>11</td><td>-0.39</td><td>-1.04</td><td>0.399</td><td>0.927</td><td>1.000</td><td>1266</td><td>tags=27%, list=10%, signal=30%</td></tr><tr><td class='lessen'>167</td><td>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP</td><td></td><td>10</td><td>-0.41</td><td>-1.04</td><td>0.434</td><td>0.922</td><td>1.000</td><td>2637</td><td>tags=50%, list=22%, signal=64%</td></tr><tr><td class='lessen'>168</td><td>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN</td><td></td><td>40</td><td>-0.27</td><td>-1.04</td><td>0.388</td><td>0.917</td><td>1.000</td><td>2356</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>169</td><td>KORKOLA_TERATOMA_UP</td><td></td><td>13</td><td>-0.38</td><td>-1.03</td><td>0.439</td><td>0.927</td><td>1.000</td><td>2566</td><td>tags=38%, list=21%, signal=49%</td></tr><tr><td class='lessen'>170</td><td>TIEN_INTESTINE_PROBIOTICS_6HR_UP</td><td></td><td>47</td><td>-0.26</td><td>-1.03</td><td>0.333</td><td>0.931</td><td>1.000</td><td>2749</td><td>tags=43%, list=23%, signal=55%</td></tr><tr><td class='lessen'>171</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN</td><td></td><td>10</td><td>-0.40</td><td>-1.03</td><td>0.424</td><td>0.928</td><td>1.000</td><td>3444</td><td>tags=60%, list=28%, signal=84%</td></tr><tr><td class='lessen'>172</td><td>YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN</td><td></td><td>14</td><td>-0.37</td><td>-1.03</td><td>0.414</td><td>0.926</td><td>1.000</td><td>578</td><td>tags=14%, list=5%, signal=15%</td></tr><tr><td class='lessen'>173</td><td>PHESSE_TARGETS_OF_APC_AND_MBD2_UP</td><td></td><td>12</td><td>-0.38</td><td>-1.03</td><td>0.435</td><td>0.924</td><td>1.000</td><td>1685</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>174</td><td>BECKER_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>44</td><td>-0.27</td><td>-1.02</td><td>0.426</td><td>0.927</td><td>1.000</td><td>604</td><td>tags=14%, list=5%, signal=14%</td></tr><tr><td class='lessen'>175</td><td>ZHANG_GATA6_TARGETS_UP</td><td></td><td>13</td><td>-0.37</td><td>-1.02</td><td>0.435</td><td>0.930</td><td>1.000</td><td>2</td><td>tags=8%, list=0%, signal=8%</td></tr><tr><td class='lessen'>176</td><td>NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON</td><td></td><td>35</td><td>-0.28</td><td>-1.02</td><td>0.410</td><td>0.930</td><td>1.000</td><td>2069</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>177</td><td>BURTON_ADIPOGENESIS_4</td><td></td><td>39</td><td>-0.27</td><td>-1.02</td><td>0.427</td><td>0.928</td><td>1.000</td><td>2936</td><td>tags=44%, list=24%, signal=57%</td></tr><tr><td class='lessen'>178</td><td>SCIBETTA_KDM5B_TARGETS_UP</td><td></td><td>13</td><td>-0.36</td><td>-1.02</td><td>0.443</td><td>0.927</td><td>1.000</td><td>6</td><td>tags=8%, list=0%, signal=8%</td></tr><tr><td class='lessen'>179</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</td><td></td><td>239</td><td>-0.20</td><td>-1.02</td><td>0.417</td><td>0.927</td><td>1.000</td><td>2492</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>180</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_DN</td><td></td><td>74</td><td>-0.24</td><td>-1.01</td><td>0.445</td><td>0.942</td><td>1.000</td><td>1770</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>181</td><td>NADLER_HYPERGLYCEMIA_AT_OBESITY</td><td></td><td>53</td><td>-0.25</td><td>-1.01</td><td>0.405</td><td>0.943</td><td>1.000</td><td>2194</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>182</td><td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN</td><td></td><td>36</td><td>-0.28</td><td>-1.01</td><td>0.484</td><td>0.940</td><td>1.000</td><td>2357</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>183</td><td>LI_ADIPOGENESIS_BY_ACTIVATED_PPARG</td><td></td><td>16</td><td>-0.34</td><td>-1.01</td><td>0.453</td><td>0.953</td><td>1.000</td><td>3553</td><td>tags=75%, list=29%, signal=106%</td></tr><tr><td class='lessen'>184</td><td>VALK_AML_CLUSTER_13</td><td></td><td>22</td><td>-0.31</td><td>-1.00</td><td>0.412</td><td>0.954</td><td>1.000</td><td>1240</td><td>tags=23%, list=10%, signal=25%</td></tr><tr><td class='lessen'>185</td><td>SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP</td><td></td><td>12</td><td>-0.37</td><td>-1.00</td><td>0.454</td><td>0.958</td><td>1.000</td><td>1301</td><td>tags=33%, list=11%, signal=37%</td></tr><tr><td class='lessen'>186</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_4_DN</td><td></td><td>11</td><td>-0.38</td><td>-1.00</td><td>0.461</td><td>0.956</td><td>1.000</td><td>1039</td><td>tags=27%, list=9%, signal=30%</td></tr><tr><td class='lessen'>187</td><td>WEBER_METHYLATED_HCP_IN_SPERM_DN</td><td></td><td>16</td><td>-0.34</td><td>-1.00</td><td>0.470</td><td>0.964</td><td>1.000</td><td>488</td><td>tags=25%, list=4%, signal=26%</td></tr><tr><td class='lessen'>188</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>26</td><td>-0.30</td><td>-1.00</td><td>0.471</td><td>0.962</td><td>1.000</td><td>273</td><td>tags=15%, list=2%, signal=16%</td></tr><tr><td class='lessen'>189</td><td>JIANG_AGING_CEREBRAL_CORTEX_UP</td><td></td><td>33</td><td>-0.27</td><td>-1.00</td><td>0.444</td><td>0.960</td><td>1.000</td><td>1700</td><td>tags=27%, list=14%, signal=32%</td></tr><tr><td class='lessen'>190</td><td>HOSHIDA_LIVER_CANCER_SURVIVAL_DN</td><td></td><td>90</td><td>-0.22</td><td>-0.99</td><td>0.514</td><td>0.961</td><td>1.000</td><td>1748</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>191</td><td>ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL</td><td></td><td>11</td><td>-0.37</td><td>-0.99</td><td>0.452</td><td>0.956</td><td>1.000</td><td>1475</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>192</td><td>MOOTHA_GLYCOGEN_METABOLISM</td><td></td><td>16</td><td>-0.34</td><td>-0.99</td><td>0.471</td><td>0.952</td><td>1.000</td><td>2158</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>193</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_3</td><td></td><td>26</td><td>-0.30</td><td>-0.99</td><td>0.502</td><td>0.954</td><td>1.000</td><td>937</td><td>tags=23%, list=8%, signal=25%</td></tr><tr><td class='lessen'>194</td><td>YANG_MUC2_TARGETS_DUODENUM_3MO_DN</td><td></td><td>16</td><td>-0.34</td><td>-0.99</td><td>0.434</td><td>0.951</td><td>1.000</td><td>2113</td><td>tags=38%, list=17%, signal=45%</td></tr><tr><td class='lessen'>195</td><td>CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY</td><td></td><td>21</td><td>-0.32</td><td>-0.99</td><td>0.487</td><td>0.952</td><td>1.000</td><td>356</td><td>tags=14%, list=3%, signal=15%</td></tr><tr><td class='lessen'>196</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN</td><td></td><td>61</td><td>-0.24</td><td>-0.99</td><td>0.455</td><td>0.954</td><td>1.000</td><td>2140</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>197</td><td>MA_PITUITARY_FETAL_VS_ADULT_UP</td><td></td><td>22</td><td>-0.30</td><td>-0.99</td><td>0.469</td><td>0.955</td><td>1.000</td><td>1896</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>198</td><td>NAKAMURA_ADIPOGENESIS_EARLY_UP</td><td></td><td>49</td><td>-0.25</td><td>-0.98</td><td>0.492</td><td>0.958</td><td>1.000</td><td>3476</td><td>tags=49%, list=29%, signal=68%</td></tr><tr><td class='lessen'>199</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_3</td><td></td><td>43</td><td>-0.26</td><td>-0.98</td><td>0.526</td><td>0.958</td><td>1.000</td><td>2481</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>200</td><td>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP</td><td></td><td>63</td><td>-0.23</td><td>-0.98</td><td>0.500</td><td>0.955</td><td>1.000</td><td>678</td><td>tags=11%, list=6%, signal=12%</td></tr><tr><td class='lessen'>201</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP</td><td></td><td>164</td><td>-0.20</td><td>-0.98</td><td>0.490</td><td>0.956</td><td>1.000</td><td>1554</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>202</td><td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN</td><td></td><td>106</td><td>-0.22</td><td>-0.98</td><td>0.458</td><td>0.955</td><td>1.000</td><td>2968</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>203</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP</td><td></td><td>22</td><td>-0.31</td><td>-0.98</td><td>0.507</td><td>0.951</td><td>1.000</td><td>1939</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>204</td><td>MA_PITUITARY_FETAL_VS_ADULT_DN</td><td></td><td>13</td><td>-0.35</td><td>-0.98</td><td>0.496</td><td>0.950</td><td>1.000</td><td>1527</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>205</td><td>VICENT_METASTASIS_UP</td><td></td><td>13</td><td>-0.34</td><td>-0.98</td><td>0.439</td><td>0.955</td><td>1.000</td><td>635</td><td>tags=23%, list=5%, signal=24%</td></tr><tr><td class='lessen'>206</td><td>CHANDRAN_METASTASIS_TOP50_UP</td><td></td><td>28</td><td>-0.29</td><td>-0.97</td><td>0.504</td><td>0.953</td><td>1.000</td><td>2617</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>207</td><td>GRADE_COLON_VS_RECTAL_CANCER_UP</td><td></td><td>30</td><td>-0.28</td><td>-0.97</td><td>0.498</td><td>0.949</td><td>1.000</td><td>2466</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>208</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP</td><td></td><td>22</td><td>-0.29</td><td>-0.97</td><td>0.451</td><td>0.945</td><td>1.000</td><td>4037</td><td>tags=50%, list=33%, signal=75%</td></tr><tr><td class='lessen'>209</td><td>IVANOV_MUTATED_IN_COLON_CANCER</td><td></td><td>10</td><td>-0.38</td><td>-0.97</td><td>0.472</td><td>0.941</td><td>1.000</td><td>2073</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>210</td><td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP</td><td></td><td>16</td><td>-0.33</td><td>-0.97</td><td>0.505</td><td>0.944</td><td>1.000</td><td>1700</td><td>tags=38%, list=14%, signal=44%</td></tr><tr><td class='lessen'>211</td><td>NIELSEN_SCHWANNOMA_DN</td><td></td><td>14</td><td>-0.35</td><td>-0.97</td><td>0.466</td><td>0.948</td><td>1.000</td><td>1968</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>212</td><td>STEIN_ESRRA_TARGETS_DN</td><td></td><td>79</td><td>-0.22</td><td>-0.96</td><td>0.531</td><td>0.961</td><td>1.000</td><td>1176</td><td>tags=15%, list=10%, signal=17%</td></tr><tr><td class='lessen'>213</td><td>BROWNE_HCMV_INFECTION_1HR_UP</td><td></td><td>51</td><td>-0.24</td><td>-0.96</td><td>0.531</td><td>0.960</td><td>1.000</td><td>1441</td><td>tags=22%, list=12%, signal=24%</td></tr><tr><td class='lessen'>214</td><td>LOPEZ_EPITHELIOID_MESOTHELIOMA</td><td></td><td>13</td><td>-0.36</td><td>-0.96</td><td>0.499</td><td>0.966</td><td>1.000</td><td>546</td><td>tags=23%, list=5%, signal=24%</td></tr><tr><td class='lessen'>215</td><td>MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4</td><td></td><td>16</td><td>-0.33</td><td>-0.96</td><td>0.520</td><td>0.963</td><td>1.000</td><td>5</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>216</td><td>FARDIN_HYPOXIA_11</td><td></td><td>25</td><td>-0.29</td><td>-0.96</td><td>0.532</td><td>0.961</td><td>1.000</td><td>2429</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>217</td><td>AMUNDSON_GAMMA_RADIATION_RESISTANCE</td><td></td><td>15</td><td>-0.33</td><td>-0.96</td><td>0.450</td><td>0.965</td><td>1.000</td><td>920</td><td>tags=27%, list=8%, signal=29%</td></tr><tr><td class='lessen'>218</td><td>STAEGE_EWING_FAMILY_TUMOR</td><td></td><td>24</td><td>-0.29</td><td>-0.96</td><td>0.515</td><td>0.967</td><td>1.000</td><td>2557</td><td>tags=46%, list=21%, signal=58%</td></tr><tr><td class='lessen'>219</td><td>MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8</td><td></td><td>12</td><td>-0.35</td><td>-0.95</td><td>0.494</td><td>0.964</td><td>1.000</td><td>3888</td><td>tags=67%, list=32%, signal=98%</td></tr><tr><td class='lessen'>220</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN</td><td></td><td>54</td><td>-0.24</td><td>-0.95</td><td>0.527</td><td>0.960</td><td>1.000</td><td>3221</td><td>tags=41%, list=27%, signal=55%</td></tr><tr><td class='lessen'>221</td><td>MCBRYAN_PUBERTAL_BREAST_5_6WK_DN</td><td></td><td>111</td><td>-0.21</td><td>-0.95</td><td>0.662</td><td>0.958</td><td>1.000</td><td>2533</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>222</td><td>WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN</td><td></td><td>11</td><td>-0.35</td><td>-0.95</td><td>0.488</td><td>0.954</td><td>1.000</td><td>371</td><td>tags=27%, list=3%, signal=28%</td></tr><tr><td class='lessen'>223</td><td>GUO_HEX_TARGETS_DN</td><td></td><td>55</td><td>-0.24</td><td>-0.95</td><td>0.571</td><td>0.953</td><td>1.000</td><td>2387</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>224</td><td>CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP</td><td></td><td>19</td><td>-0.30</td><td>-0.95</td><td>0.549</td><td>0.966</td><td>1.000</td><td>2681</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>225</td><td>SABATES_COLORECTAL_ADENOMA_SIZE_UP</td><td></td><td>15</td><td>-0.33</td><td>-0.95</td><td>0.492</td><td>0.963</td><td>1.000</td><td>2225</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>226</td><td>THUM_SYSTOLIC_HEART_FAILURE_DN</td><td></td><td>169</td><td>-0.20</td><td>-0.95</td><td>0.611</td><td>0.960</td><td>1.000</td><td>2044</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>227</td><td>HASLINGER_B_CLL_WITH_11Q23_DELETION</td><td></td><td>21</td><td>-0.30</td><td>-0.95</td><td>0.525</td><td>0.961</td><td>1.000</td><td>2242</td><td>tags=38%, list=18%, signal=47%</td></tr><tr><td class='lessen'>228</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</td><td></td><td>26</td><td>-0.28</td><td>-0.94</td><td>0.547</td><td>0.970</td><td>1.000</td><td>1496</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>229</td><td>NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN</td><td></td><td>12</td><td>-0.35</td><td>-0.94</td><td>0.512</td><td>0.968</td><td>1.000</td><td>2046</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>230</td><td>MAHADEVAN_IMATINIB_RESISTANCE_DN</td><td></td><td>15</td><td>-0.32</td><td>-0.94</td><td>0.530</td><td>0.966</td><td>1.000</td><td>2112</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>231</td><td>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>66</td><td>-0.23</td><td>-0.94</td><td>0.623</td><td>0.965</td><td>1.000</td><td>2780</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>232</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN</td><td></td><td>21</td><td>-0.28</td><td>-0.94</td><td>0.534</td><td>0.963</td><td>1.000</td><td>1466</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>233</td><td>JEON_SMAD6_TARGETS_UP</td><td></td><td>19</td><td>-0.31</td><td>-0.94</td><td>0.528</td><td>0.960</td><td>1.000</td><td>595</td><td>tags=11%, list=5%, signal=11%</td></tr><tr><td class='lessen'>234</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP</td><td></td><td>14</td><td>-0.33</td><td>-0.94</td><td>0.551</td><td>0.959</td><td>1.000</td><td>807</td><td>tags=21%, list=7%, signal=23%</td></tr><tr><td class='lessen'>235</td><td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP</td><td></td><td>10</td><td>-0.37</td><td>-0.94</td><td>0.549</td><td>0.957</td><td>1.000</td><td>701</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>236</td><td>SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN</td><td></td><td>15</td><td>-0.33</td><td>-0.94</td><td>0.546</td><td>0.955</td><td>1.000</td><td>3358</td><td>tags=47%, list=28%, signal=64%</td></tr><tr><td class='lessen'>237</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP</td><td></td><td>34</td><td>-0.25</td><td>-0.93</td><td>0.595</td><td>0.963</td><td>1.000</td><td>2462</td><td>tags=29%, list=20%, signal=37%</td></tr><tr><td class='lessen'>238</td><td>STREICHER_LSM1_TARGETS_UP</td><td></td><td>40</td><td>-0.25</td><td>-0.93</td><td>0.596</td><td>0.964</td><td>1.000</td><td>1391</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>239</td><td>ZHAN_MULTIPLE_MYELOMA_LB_UP</td><td></td><td>33</td><td>-0.26</td><td>-0.93</td><td>0.604</td><td>0.963</td><td>1.000</td><td>2211</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>240</td><td>LEE_CALORIE_RESTRICTION_MUSCLE_UP</td><td></td><td>34</td><td>-0.25</td><td>-0.93</td><td>0.566</td><td>0.962</td><td>1.000</td><td>1112</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>241</td><td>GAVIN_PDE3B_TARGETS</td><td></td><td>20</td><td>-0.29</td><td>-0.93</td><td>0.508</td><td>0.960</td><td>1.000</td><td>1589</td><td>tags=30%, list=13%, signal=34%</td></tr><tr><td class='lessen'>242</td><td>GENTILE_UV_RESPONSE_CLUSTER_D7</td><td></td><td>33</td><td>-0.26</td><td>-0.93</td><td>0.586</td><td>0.959</td><td>1.000</td><td>667</td><td>tags=9%, list=5%, signal=10%</td></tr><tr><td class='lessen'>243</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</td><td></td><td>44</td><td>-0.24</td><td>-0.92</td><td>0.630</td><td>0.960</td><td>1.000</td><td>1690</td><td>tags=27%, list=14%, signal=32%</td></tr><tr><td class='lessen'>244</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN</td><td></td><td>26</td><td>-0.26</td><td>-0.92</td><td>0.614</td><td>0.971</td><td>1.000</td><td>3642</td><td>tags=50%, list=30%, signal=71%</td></tr><tr><td class='lessen'>245</td><td>ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN</td><td></td><td>14</td><td>-0.33</td><td>-0.92</td><td>0.526</td><td>0.968</td><td>1.000</td><td>1432</td><td>tags=36%, list=12%, signal=40%</td></tr><tr><td class='lessen'>246</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</td><td></td><td>45</td><td>-0.24</td><td>-0.92</td><td>0.603</td><td>0.967</td><td>1.000</td><td>2357</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>247</td><td>BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER</td><td></td><td>22</td><td>-0.29</td><td>-0.92</td><td>0.573</td><td>0.966</td><td>1.000</td><td>774</td><td>tags=23%, list=6%, signal=24%</td></tr><tr><td class='lessen'>248</td><td>WONG_IFNA2_RESISTANCE_DN</td><td></td><td>28</td><td>-0.27</td><td>-0.92</td><td>0.608</td><td>0.968</td><td>1.000</td><td>1408</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>249</td><td>DAZARD_UV_RESPONSE_CLUSTER_G6</td><td></td><td>118</td><td>-0.20</td><td>-0.91</td><td>0.775</td><td>0.971</td><td>1.000</td><td>2946</td><td>tags=34%, list=24%, signal=44%</td></tr><tr><td class='lessen'>250</td><td>MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP</td><td></td><td>20</td><td>-0.29</td><td>-0.91</td><td>0.571</td><td>0.974</td><td>1.000</td><td>345</td><td>tags=10%, list=3%, signal=10%</td></tr><tr><td class='lessen'>251</td><td>MA_MYELOID_DIFFERENTIATION_UP</td><td></td><td>38</td><td>-0.24</td><td>-0.91</td><td>0.655</td><td>0.971</td><td>1.000</td><td>1746</td><td>tags=21%, list=14%, signal=25%</td></tr><tr><td class='lessen'>252</td><td>VALK_AML_CLUSTER_1</td><td></td><td>25</td><td>-0.28</td><td>-0.91</td><td>0.598</td><td>0.978</td><td>1.000</td><td>1979</td><td>tags=40%, list=16%, signal=48%</td></tr><tr><td class='lessen'>253</td><td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN</td><td></td><td>17</td><td>-0.30</td><td>-0.91</td><td>0.553</td><td>0.977</td><td>1.000</td><td>1805</td><td>tags=35%, list=15%, signal=41%</td></tr><tr><td class='lessen'>254</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN</td><td></td><td>44</td><td>-0.23</td><td>-0.91</td><td>0.663</td><td>0.975</td><td>1.000</td><td>3597</td><td>tags=43%, list=30%, signal=61%</td></tr><tr><td class='lessen'>255</td><td>NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP</td><td></td><td>15</td><td>-0.32</td><td>-0.90</td><td>0.573</td><td>0.975</td><td>1.000</td><td>1277</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>256</td><td>CAFFAREL_RESPONSE_TO_THC_8HR_5_UP</td><td></td><td>11</td><td>-0.34</td><td>-0.90</td><td>0.589</td><td>0.972</td><td>1.000</td><td>1894</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>257</td><td>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN</td><td></td><td>46</td><td>-0.23</td><td>-0.90</td><td>0.663</td><td>0.968</td><td>1.000</td><td>3781</td><td>tags=41%, list=31%, signal=60%</td></tr><tr><td class='lessen'>258</td><td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP</td><td></td><td>29</td><td>-0.26</td><td>-0.90</td><td>0.618</td><td>0.967</td><td>1.000</td><td>39</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>259</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN</td><td></td><td>30</td><td>-0.26</td><td>-0.90</td><td>0.602</td><td>0.964</td><td>1.000</td><td>2256</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>260</td><td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</td><td></td><td>74</td><td>-0.21</td><td>-0.90</td><td>0.710</td><td>0.964</td><td>1.000</td><td>825</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>261</td><td>NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER</td><td></td><td>16</td><td>-0.31</td><td>-0.90</td><td>0.611</td><td>0.961</td><td>1.000</td><td>763</td><td>tags=19%, list=6%, signal=20%</td></tr><tr><td class='lessen'>262</td><td>YANG_BREAST_CANCER_ESR1_LASER_UP</td><td></td><td>25</td><td>-0.27</td><td>-0.90</td><td>0.656</td><td>0.959</td><td>1.000</td><td>1706</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>263</td><td>FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP</td><td></td><td>15</td><td>-0.31</td><td>-0.90</td><td>0.601</td><td>0.958</td><td>1.000</td><td>2178</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>264</td><td>TING_SILENCED_BY_DICER</td><td></td><td>23</td><td>-0.28</td><td>-0.90</td><td>0.623</td><td>0.959</td><td>1.000</td><td>1426</td><td>tags=17%, list=12%, signal=20%</td></tr><tr><td class='lessen'>265</td><td>HASINA_NOL7_TARGETS_DN</td><td></td><td>11</td><td>-0.34</td><td>-0.90</td><td>0.601</td><td>0.957</td><td>1.000</td><td>1592</td><td>tags=36%, list=13%, signal=42%</td></tr><tr><td class='lessen'>266</td><td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN</td><td></td><td>34</td><td>-0.24</td><td>-0.90</td><td>0.657</td><td>0.957</td><td>1.000</td><td>1781</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>267</td><td>NAGASHIMA_NRG1_SIGNALING_DN</td><td></td><td>38</td><td>-0.24</td><td>-0.89</td><td>0.677</td><td>0.960</td><td>1.000</td><td>1177</td><td>tags=16%, list=10%, signal=17%</td></tr><tr><td class='lessen'>268</td><td>STAMBOLSKY_BOUND_BY_MUTATED_TP53</td><td></td><td>13</td><td>-0.32</td><td>-0.89</td><td>0.601</td><td>0.959</td><td>1.000</td><td>872</td><td>tags=15%, list=7%, signal=17%</td></tr><tr><td class='lessen'>269</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN</td><td></td><td>66</td><td>-0.21</td><td>-0.89</td><td>0.688</td><td>0.960</td><td>1.000</td><td>1738</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>270</td><td>DELACROIX_RAR_TARGETS_DN</td><td></td><td>22</td><td>-0.28</td><td>-0.89</td><td>0.590</td><td>0.959</td><td>1.000</td><td>2712</td><td>tags=41%, list=22%, signal=53%</td></tr><tr><td class='lessen'>271</td><td>GABRIELY_MIR21_TARGETS</td><td></td><td>241</td><td>-0.17</td><td>-0.89</td><td>0.875</td><td>0.960</td><td>1.000</td><td>3124</td><td>tags=32%, list=26%, signal=43%</td></tr><tr><td class='lessen'>272</td><td>MATZUK_SPERMATID_DIFFERENTIATION</td><td></td><td>28</td><td>-0.26</td><td>-0.89</td><td>0.669</td><td>0.959</td><td>1.000</td><td>2147</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>273</td><td>BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP</td><td></td><td>15</td><td>-0.30</td><td>-0.89</td><td>0.650</td><td>0.956</td><td>1.000</td><td>2288</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>274</td><td>TOMLINS_METASTASIS_UP</td><td></td><td>13</td><td>-0.32</td><td>-0.88</td><td>0.605</td><td>0.962</td><td>1.000</td><td>1323</td><td>tags=46%, list=11%, signal=52%</td></tr><tr><td class='lessen'>275</td><td>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP</td><td></td><td>48</td><td>-0.23</td><td>-0.88</td><td>0.719</td><td>0.961</td><td>1.000</td><td>1174</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>276</td><td>FERRANDO_LYL1_NEIGHBORS</td><td></td><td>15</td><td>-0.30</td><td>-0.88</td><td>0.632</td><td>0.958</td><td>1.000</td><td>3003</td><td>tags=47%, list=25%, signal=62%</td></tr><tr><td class='lessen'>277</td><td>MATZUK_EARLY_ANTRAL_FOLLICLE</td><td></td><td>12</td><td>-0.32</td><td>-0.88</td><td>0.605</td><td>0.963</td><td>1.000</td><td>2916</td><td>tags=50%, list=24%, signal=66%</td></tr><tr><td class='lessen'>278</td><td>BYSTROEM_CORRELATED_WITH_IL5_DN</td><td></td><td>59</td><td>-0.22</td><td>-0.88</td><td>0.711</td><td>0.960</td><td>1.000</td><td>2874</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>279</td><td>GENTILE_UV_RESPONSE_CLUSTER_D4</td><td></td><td>46</td><td>-0.23</td><td>-0.88</td><td>0.736</td><td>0.956</td><td>1.000</td><td>2312</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>280</td><td>MAEKAWA_ATF2_TARGETS</td><td></td><td>20</td><td>-0.28</td><td>-0.88</td><td>0.630</td><td>0.954</td><td>1.000</td><td>1712</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>281</td><td>GENTILE_UV_RESPONSE_CLUSTER_D5</td><td></td><td>30</td><td>-0.25</td><td>-0.88</td><td>0.671</td><td>0.955</td><td>1.000</td><td>2531</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>282</td><td>WANG_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>24</td><td>-0.26</td><td>-0.87</td><td>0.676</td><td>0.959</td><td>1.000</td><td>1010</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>283</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN</td><td></td><td>21</td><td>-0.28</td><td>-0.87</td><td>0.629</td><td>0.957</td><td>1.000</td><td>1551</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>284</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP</td><td></td><td>19</td><td>-0.28</td><td>-0.87</td><td>0.641</td><td>0.960</td><td>1.000</td><td>3123</td><td>tags=47%, list=26%, signal=64%</td></tr><tr><td class='lessen'>285</td><td>VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN</td><td></td><td>12</td><td>-0.33</td><td>-0.87</td><td>0.605</td><td>0.960</td><td>1.000</td><td>1446</td><td>tags=33%, list=12%, signal=38%</td></tr><tr><td class='lessen'>286</td><td>LEE_SP4_THYMOCYTE</td><td></td><td>11</td><td>-0.33</td><td>-0.87</td><td>0.643</td><td>0.957</td><td>1.000</td><td>1165</td><td>tags=36%, list=10%, signal=40%</td></tr><tr><td class='lessen'>287</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN</td><td></td><td>37</td><td>-0.24</td><td>-0.87</td><td>0.692</td><td>0.958</td><td>1.000</td><td>1919</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>288</td><td>TOMLINS_PROSTATE_CANCER_DN</td><td></td><td>36</td><td>-0.25</td><td>-0.86</td><td>0.753</td><td>0.970</td><td>1.000</td><td>3794</td><td>tags=50%, list=31%, signal=73%</td></tr><tr><td class='lessen'>289</td><td>YANAGIHARA_ESX1_TARGETS</td><td></td><td>25</td><td>-0.25</td><td>-0.86</td><td>0.709</td><td>0.976</td><td>1.000</td><td>2733</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>290</td><td>MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER</td><td></td><td>36</td><td>-0.24</td><td>-0.85</td><td>0.750</td><td>0.980</td><td>1.000</td><td>2704</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>291</td><td>CHEN_ETV5_TARGETS_TESTIS</td><td></td><td>18</td><td>-0.28</td><td>-0.85</td><td>0.684</td><td>0.981</td><td>1.000</td><td>1916</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>292</td><td>PUJANA_BREAST_CANCER_LIT_INT_NETWORK</td><td></td><td>93</td><td>-0.19</td><td>-0.85</td><td>0.789</td><td>0.981</td><td>1.000</td><td>3189</td><td>tags=35%, list=26%, signal=48%</td></tr><tr><td class='lessen'>293</td><td>MCBRYAN_PUBERTAL_BREAST_3_4WK_DN</td><td></td><td>31</td><td>-0.24</td><td>-0.85</td><td>0.730</td><td>0.982</td><td>1.000</td><td>1292</td><td>tags=19%, list=11%, signal=22%</td></tr><tr><td class='lessen'>294</td><td>BAKER_HEMATOPOESIS_STAT1_TARGETS</td><td></td><td>10</td><td>-0.33</td><td>-0.85</td><td>0.647</td><td>0.983</td><td>1.000</td><td>870</td><td>tags=30%, list=7%, signal=32%</td></tr><tr><td class='lessen'>295</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_UP</td><td></td><td>37</td><td>-0.23</td><td>-0.85</td><td>0.738</td><td>0.980</td><td>1.000</td><td>2288</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>296</td><td>LIAO_HAVE_SOX4_BINDING_SITES</td><td></td><td>38</td><td>-0.23</td><td>-0.85</td><td>0.773</td><td>0.977</td><td>1.000</td><td>1470</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>297</td><td>WU_HBX_TARGETS_1_DN</td><td></td><td>21</td><td>-0.26</td><td>-0.84</td><td>0.709</td><td>0.980</td><td>1.000</td><td>2728</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>298</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR</td><td></td><td>30</td><td>-0.24</td><td>-0.84</td><td>0.745</td><td>0.978</td><td>1.000</td><td>3016</td><td>tags=43%, list=25%, signal=58%</td></tr><tr><td class='lessen'>299</td><td>LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q</td><td></td><td>90</td><td>-0.19</td><td>-0.84</td><td>0.869</td><td>0.975</td><td>1.000</td><td>3440</td><td>tags=31%, list=28%, signal=43%</td></tr><tr><td class='lessen'>300</td><td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP</td><td></td><td>28</td><td>-0.25</td><td>-0.84</td><td>0.738</td><td>0.973</td><td>1.000</td><td>4133</td><td>tags=50%, list=34%, signal=76%</td></tr><tr><td class='lessen'>301</td><td>MATZUK_EMBRYONIC_GERM_CELL</td><td></td><td>18</td><td>-0.28</td><td>-0.84</td><td>0.692</td><td>0.983</td><td>1.000</td><td>28</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>302</td><td>MALONEY_RESPONSE_TO_17AAG_DN</td><td></td><td>68</td><td>-0.20</td><td>-0.83</td><td>0.817</td><td>0.985</td><td>1.000</td><td>1778</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>303</td><td>RIZ_ERYTHROID_DIFFERENTIATION</td><td></td><td>68</td><td>-0.20</td><td>-0.83</td><td>0.820</td><td>0.989</td><td>1.000</td><td>3686</td><td>tags=49%, list=30%, signal=69%</td></tr><tr><td class='lessen'>304</td><td>ELVIDGE_HYPOXIA_BY_DMOG_DN</td><td></td><td>51</td><td>-0.21</td><td>-0.83</td><td>0.789</td><td>0.986</td><td>1.000</td><td>2167</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>305</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN</td><td></td><td>18</td><td>-0.27</td><td>-0.83</td><td>0.726</td><td>0.987</td><td>1.000</td><td>3438</td><td>tags=50%, list=28%, signal=70%</td></tr><tr><td class='lessen'>306</td><td>HWANG_PROSTATE_CANCER_MARKERS</td><td></td><td>25</td><td>-0.24</td><td>-0.83</td><td>0.754</td><td>0.985</td><td>1.000</td><td>2679</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>307</td><td>MATHEW_FANCONI_ANEMIA_GENES</td><td></td><td>11</td><td>-0.31</td><td>-0.83</td><td>0.687</td><td>0.985</td><td>1.000</td><td>1553</td><td>tags=36%, list=13%, signal=42%</td></tr><tr><td class='lessen'>308</td><td>ZHAN_MULTIPLE_MYELOMA_LB_DN</td><td></td><td>31</td><td>-0.23</td><td>-0.82</td><td>0.771</td><td>0.987</td><td>1.000</td><td>2398</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>309</td><td>KAYO_AGING_MUSCLE_DN</td><td></td><td>104</td><td>-0.18</td><td>-0.82</td><td>0.893</td><td>0.993</td><td>1.000</td><td>2491</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>310</td><td>KYNG_NORMAL_AGING_DN</td><td></td><td>21</td><td>-0.26</td><td>-0.82</td><td>0.808</td><td>0.994</td><td>1.000</td><td>2056</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>311</td><td>KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN</td><td></td><td>10</td><td>-0.31</td><td>-0.81</td><td>0.713</td><td>0.997</td><td>1.000</td><td>2814</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>312</td><td>WU_HBX_TARGETS_3_UP</td><td></td><td>16</td><td>-0.27</td><td>-0.81</td><td>0.740</td><td>0.996</td><td>1.000</td><td>1511</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>313</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN</td><td></td><td>13</td><td>-0.29</td><td>-0.81</td><td>0.719</td><td>0.993</td><td>1.000</td><td>3426</td><td>tags=54%, list=28%, signal=75%</td></tr><tr><td class='lessen'>314</td><td>SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY</td><td></td><td>30</td><td>-0.23</td><td>-0.81</td><td>0.779</td><td>0.995</td><td>1.000</td><td>3245</td><td>tags=33%, list=27%, signal=45%</td></tr><tr><td class='lessen'>315</td><td>WONG_IFNA2_RESISTANCE_UP</td><td></td><td>14</td><td>-0.28</td><td>-0.81</td><td>0.699</td><td>0.997</td><td>1.000</td><td>1454</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>316</td><td>HOFMANN_CELL_LYMPHOMA_UP</td><td></td><td>39</td><td>-0.21</td><td>-0.80</td><td>0.826</td><td>0.999</td><td>1.000</td><td>1354</td><td>tags=13%, list=11%, signal=14%</td></tr><tr><td class='lessen'>317</td><td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN</td><td></td><td>44</td><td>-0.21</td><td>-0.80</td><td>0.843</td><td>1.000</td><td>1.000</td><td>3926</td><td>tags=48%, list=32%, signal=70%</td></tr><tr><td class='lessen'>318</td><td>PLASARI_NFIC_TARGETS_BASAL_DN</td><td></td><td>18</td><td>-0.26</td><td>-0.80</td><td>0.779</td><td>1.000</td><td>1.000</td><td>3455</td><td>tags=50%, list=28%, signal=70%</td></tr><tr><td class='lessen'>319</td><td>THILLAINADESAN_ZNF217_TARGETS_UP</td><td></td><td>34</td><td>-0.22</td><td>-0.80</td><td>0.841</td><td>1.000</td><td>1.000</td><td>1419</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>320</td><td>ZHAN_EARLY_DIFFERENTIATION_GENES_DN</td><td></td><td>37</td><td>-0.22</td><td>-0.80</td><td>0.853</td><td>0.998</td><td>1.000</td><td>1221</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>321</td><td>JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN</td><td></td><td>72</td><td>-0.19</td><td>-0.80</td><td>0.887</td><td>0.997</td><td>1.000</td><td>1746</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>322</td><td>JIANG_VHL_TARGETS</td><td></td><td>105</td><td>-0.17</td><td>-0.80</td><td>0.980</td><td>0.995</td><td>1.000</td><td>1991</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>323</td><td>BILD_SRC_ONCOGENIC_SIGNATURE</td><td></td><td>52</td><td>-0.20</td><td>-0.79</td><td>0.900</td><td>0.994</td><td>1.000</td><td>2749</td><td>tags=37%, list=23%, signal=47%</td></tr><tr><td class='lessen'>324</td><td>ZHANG_GATA6_TARGETS_DN</td><td></td><td>56</td><td>-0.20</td><td>-0.79</td><td>0.875</td><td>0.994</td><td>1.000</td><td>1105</td><td>tags=16%, list=9%, signal=18%</td></tr><tr><td class='lessen'>325</td><td>PUJANA_BRCA_CENTERED_NETWORK</td><td></td><td>107</td><td>-0.17</td><td>-0.79</td><td>0.923</td><td>0.999</td><td>1.000</td><td>3189</td><td>tags=31%, list=26%, signal=41%</td></tr><tr><td class='lessen'>326</td><td>HASLINGER_B_CLL_WITH_17P13_DELETION</td><td></td><td>18</td><td>-0.25</td><td>-0.78</td><td>0.807</td><td>1.000</td><td>1.000</td><td>751</td><td>tags=11%, list=6%, signal=12%</td></tr><tr><td class='lessen'>327</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td><td></td><td>85</td><td>-0.18</td><td>-0.77</td><td>0.953</td><td>1.000</td><td>1.000</td><td>2337</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>328</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN</td><td></td><td>203</td><td>-0.15</td><td>-0.77</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2535</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>329</td><td>ROME_INSULIN_TARGETS_IN_MUSCLE_UP</td><td></td><td>343</td><td>-0.14</td><td>-0.77</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2560</td><td>tags=20%, list=21%, signal=24%</td></tr><tr><td class='lessen'>330</td><td>CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB</td><td></td><td>14</td><td>-0.27</td><td>-0.77</td><td>0.766</td><td>1.000</td><td>1.000</td><td>3377</td><td>tags=36%, list=28%, signal=49%</td></tr><tr><td class='lessen'>331</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td><td></td><td>99</td><td>-0.17</td><td>-0.76</td><td>0.923</td><td>1.000</td><td>1.000</td><td>3643</td><td>tags=40%, list=30%, signal=57%</td></tr><tr><td class='lessen'>332</td><td>KONDO_COLON_CANCER_HCP_WITH_H3K27ME1</td><td></td><td>19</td><td>-0.25</td><td>-0.76</td><td>0.811</td><td>1.000</td><td>1.000</td><td>3085</td><td>tags=37%, list=25%, signal=49%</td></tr><tr><td class='lessen'>333</td><td>GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION</td><td></td><td>12</td><td>-0.28</td><td>-0.76</td><td>0.791</td><td>1.000</td><td>1.000</td><td>3213</td><td>tags=42%, list=26%, signal=57%</td></tr><tr><td class='lessen'>334</td><td>JAIN_NFKB_SIGNALING</td><td></td><td>65</td><td>-0.18</td><td>-0.76</td><td>0.904</td><td>1.000</td><td>1.000</td><td>2995</td><td>tags=26%, list=25%, signal=35%</td></tr><tr><td class='lessen'>335</td><td>MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN</td><td></td><td>11</td><td>-0.30</td><td>-0.75</td><td>0.769</td><td>1.000</td><td>1.000</td><td>389</td><td>tags=18%, list=3%, signal=19%</td></tr><tr><td class='lessen'>336</td><td>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN</td><td></td><td>12</td><td>-0.27</td><td>-0.75</td><td>0.817</td><td>1.000</td><td>1.000</td><td>4185</td><td>tags=42%, list=35%, signal=64%</td></tr><tr><td class='lessen'>337</td><td>KAYO_CALORIE_RESTRICTION_MUSCLE_DN</td><td></td><td>69</td><td>-0.18</td><td>-0.75</td><td>0.938</td><td>1.000</td><td>1.000</td><td>403</td><td>tags=4%, list=3%, signal=4%</td></tr><tr><td class='lessen'>338</td><td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN</td><td></td><td>10</td><td>-0.30</td><td>-0.75</td><td>0.769</td><td>1.000</td><td>1.000</td><td>281</td><td>tags=10%, list=2%, signal=10%</td></tr><tr><td class='lessen'>339</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN</td><td></td><td>10</td><td>-0.29</td><td>-0.75</td><td>0.797</td><td>1.000</td><td>1.000</td><td>1949</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>340</td><td>BOYLAN_MULTIPLE_MYELOMA_C_UP</td><td></td><td>36</td><td>-0.20</td><td>-0.74</td><td>0.912</td><td>1.000</td><td>1.000</td><td>2069</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>341</td><td>BILD_CTNNB1_ONCOGENIC_SIGNATURE</td><td></td><td>57</td><td>-0.18</td><td>-0.74</td><td>0.928</td><td>1.000</td><td>1.000</td><td>2533</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>342</td><td>CHANG_CORE_SERUM_RESPONSE_DN</td><td></td><td>155</td><td>-0.16</td><td>-0.74</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3518</td><td>tags=37%, list=29%, signal=51%</td></tr><tr><td class='lessen'>343</td><td>PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP</td><td></td><td>15</td><td>-0.26</td><td>-0.74</td><td>0.794</td><td>1.000</td><td>1.000</td><td>4743</td><td>tags=67%, list=39%, signal=109%</td></tr><tr><td class='lessen'>344</td><td>SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP</td><td></td><td>23</td><td>-0.24</td><td>-0.74</td><td>0.856</td><td>1.000</td><td>1.000</td><td>2102</td><td>tags=30%, list=17%, signal=37%</td></tr><tr><td class='lessen'>345</td><td>AMIT_EGF_RESPONSE_240_HELA</td><td></td><td>54</td><td>-0.18</td><td>-0.73</td><td>0.954</td><td>1.000</td><td>1.000</td><td>2429</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>346</td><td>HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP</td><td></td><td>15</td><td>-0.25</td><td>-0.73</td><td>0.816</td><td>1.000</td><td>1.000</td><td>1576</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>347</td><td>ELVIDGE_HYPOXIA_DN</td><td></td><td>123</td><td>-0.16</td><td>-0.73</td><td>0.987</td><td>1.000</td><td>1.000</td><td>2332</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>348</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>46</td><td>-0.18</td><td>-0.73</td><td>0.916</td><td>1.000</td><td>1.000</td><td>3651</td><td>tags=39%, list=30%, signal=56%</td></tr><tr><td class='lessen'>349</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP</td><td></td><td>23</td><td>-0.22</td><td>-0.72</td><td>0.874</td><td>1.000</td><td>1.000</td><td>1573</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>350</td><td>WAESCH_ANAPHASE_PROMOTING_COMPLEX</td><td></td><td>12</td><td>-0.26</td><td>-0.71</td><td>0.811</td><td>1.000</td><td>1.000</td><td>4338</td><td>tags=58%, list=36%, signal=91%</td></tr><tr><td class='lessen'>351</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_5</td><td></td><td>16</td><td>-0.24</td><td>-0.71</td><td>0.874</td><td>1.000</td><td>1.000</td><td>1539</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>352</td><td>TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN</td><td></td><td>30</td><td>-0.20</td><td>-0.71</td><td>0.933</td><td>1.000</td><td>1.000</td><td>3506</td><td>tags=43%, list=29%, signal=61%</td></tr><tr><td class='lessen'>353</td><td>MCDOWELL_ACUTE_LUNG_INJURY_DN</td><td></td><td>37</td><td>-0.19</td><td>-0.71</td><td>0.912</td><td>1.000</td><td>1.000</td><td>2222</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>354</td><td>LEE_METASTASIS_AND_RNA_PROCESSING_UP</td><td></td><td>15</td><td>-0.24</td><td>-0.70</td><td>0.876</td><td>1.000</td><td>1.000</td><td>9177</td><td>tags=100%, list=76%, signal=410%</td></tr><tr><td class='lessen'>355</td><td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td><td></td><td>104</td><td>-0.15</td><td>-0.70</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2589</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>356</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN</td><td></td><td>120</td><td>-0.15</td><td>-0.70</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3608</td><td>tags=38%, list=30%, signal=54%</td></tr><tr><td class='lessen'>357</td><td>HOEGERKORP_CD44_TARGETS_DIRECT_DN</td><td></td><td>12</td><td>-0.26</td><td>-0.70</td><td>0.846</td><td>1.000</td><td>1.000</td><td>9033</td><td>tags=100%, list=74%, signal=391%</td></tr><tr><td class='lessen'>358</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN</td><td></td><td>26</td><td>-0.21</td><td>-0.69</td><td>0.917</td><td>1.000</td><td>1.000</td><td>1177</td><td>tags=15%, list=10%, signal=17%</td></tr><tr><td class='lessen'>359</td><td>ZHANG_INTERFERON_RESPONSE</td><td></td><td>17</td><td>-0.23</td><td>-0.69</td><td>0.898</td><td>1.000</td><td>1.000</td><td>9304</td><td>tags=100%, list=77%, signal=429%</td></tr><tr><td class='lessen'>360</td><td>NOUZOVA_TRETINOIN_AND_H4_ACETYLATION</td><td></td><td>99</td><td>-0.15</td><td>-0.69</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3334</td><td>tags=25%, list=27%, signal=35%</td></tr><tr><td class='lessen'>361</td><td>LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED</td><td></td><td>14</td><td>-0.24</td><td>-0.68</td><td>0.877</td><td>1.000</td><td>1.000</td><td>2529</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>362</td><td>MOOTHA_VOXPHOS</td><td></td><td>79</td><td>-0.16</td><td>-0.68</td><td>1.000</td><td>1.000</td><td>1.000</td><td>10193</td><td>tags=100%, list=84%, signal=622%</td></tr><tr><td class='lessen'>363</td><td>MIZUSHIMA_AUTOPHAGOSOME_FORMATION</td><td></td><td>15</td><td>-0.23</td><td>-0.68</td><td>0.867</td><td>1.000</td><td>1.000</td><td>9339</td><td>tags=100%, list=77%, signal=434%</td></tr><tr><td class='lessen'>364</td><td>COLLIS_PRKDC_REGULATORS</td><td></td><td>15</td><td>-0.23</td><td>-0.68</td><td>0.904</td><td>1.000</td><td>1.000</td><td>2679</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>365</td><td>GUO_HEX_TARGETS_UP</td><td></td><td>68</td><td>-0.16</td><td>-0.67</td><td>0.985</td><td>1.000</td><td>1.000</td><td>3057</td><td>tags=25%, list=25%, signal=33%</td></tr><tr><td class='lessen'>366</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17</td><td></td><td>16</td><td>-0.23</td><td>-0.67</td><td>0.913</td><td>1.000</td><td>1.000</td><td>1869</td><td>tags=25%, list=15%, signal=30%</td></tr><tr><td class='lessen'>367</td><td>SPIRA_SMOKERS_LUNG_CANCER_DN</td><td></td><td>14</td><td>-0.23</td><td>-0.66</td><td>0.865</td><td>1.000</td><td>1.000</td><td>9351</td><td>tags=100%, list=77%, signal=436%</td></tr><tr><td class='lessen'>368</td><td>SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN</td><td></td><td>35</td><td>-0.18</td><td>-0.66</td><td>0.968</td><td>1.000</td><td>1.000</td><td>1966</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>369</td><td>ELVIDGE_HIF1A_TARGETS_UP</td><td></td><td>54</td><td>-0.16</td><td>-0.66</td><td>0.989</td><td>1.000</td><td>1.000</td><td>2622</td><td>tags=28%, list=22%, signal=35%</td></tr><tr><td class='lessen'>370</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP</td><td></td><td>12</td><td>-0.25</td><td>-0.66</td><td>0.902</td><td>1.000</td><td>1.000</td><td>2628</td><td>tags=25%, list=22%, signal=32%</td></tr><tr><td class='lessen'>371</td><td>NIELSEN_LEIOMYOSARCOMA_UP</td><td></td><td>15</td><td>-0.22</td><td>-0.65</td><td>0.924</td><td>1.000</td><td>1.000</td><td>2026</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>372</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>333</td><td>-0.13</td><td>-0.65</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3168</td><td>tags=25%, list=26%, signal=33%</td></tr><tr><td class='lessen'>373</td><td>GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3</td><td></td><td>10</td><td>-0.25</td><td>-0.65</td><td>0.912</td><td>1.000</td><td>1.000</td><td>2046</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>374</td><td>BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS</td><td></td><td>19</td><td>-0.21</td><td>-0.64</td><td>0.946</td><td>1.000</td><td>1.000</td><td>3116</td><td>tags=37%, list=26%, signal=50%</td></tr><tr><td class='lessen'>375</td><td>LANDIS_BREAST_CANCER_PROGRESSION_DN</td><td></td><td>67</td><td>-0.15</td><td>-0.63</td><td>0.985</td><td>1.000</td><td>1.000</td><td>3455</td><td>tags=31%, list=28%, signal=44%</td></tr><tr><td class='lessen'>376</td><td>JIANG_HYPOXIA_VIA_VHL</td><td></td><td>29</td><td>-0.18</td><td>-0.63</td><td>0.965</td><td>1.000</td><td>1.000</td><td>2259</td><td>tags=24%, list=19%, signal=30%</td></tr><tr><td class='lessen'>377</td><td>XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP</td><td></td><td>15</td><td>-0.21</td><td>-0.62</td><td>0.921</td><td>1.000</td><td>1.000</td><td>2325</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>378</td><td>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN</td><td></td><td>35</td><td>-0.17</td><td>-0.61</td><td>0.980</td><td>1.000</td><td>1.000</td><td>3180</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>379</td><td>STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN</td><td></td><td>14</td><td>-0.21</td><td>-0.61</td><td>0.950</td><td>1.000</td><td>1.000</td><td>2886</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>380</td><td>SCHEIDEREIT_IKK_TARGETS</td><td></td><td>15</td><td>-0.21</td><td>-0.60</td><td>0.946</td><td>1.000</td><td>1.000</td><td>919</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>381</td><td>ZHAN_MULTIPLE_MYELOMA_SUBGROUPS</td><td></td><td>30</td><td>-0.16</td><td>-0.58</td><td>0.992</td><td>1.000</td><td>1.000</td><td>1289</td><td>tags=10%, list=11%, signal=11%</td></tr><tr><td class='lessen'>382</td><td>HASLINGER_B_CLL_WITH_6Q21_DELETION</td><td></td><td>16</td><td>-0.19</td><td>-0.57</td><td>0.968</td><td>1.000</td><td>1.000</td><td>2902</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>383</td><td>NAGY_STAGA_COMPONENTS_HUMAN</td><td></td><td>10</td><td>-0.23</td><td>-0.57</td><td>0.944</td><td>1.000</td><td>1.000</td><td>9382</td><td>tags=100%, list=77%, signal=441%</td></tr><tr><td class='lessen'>384</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP</td><td></td><td>10</td><td>-0.23</td><td>-0.56</td><td>0.950</td><td>1.000</td><td>1.000</td><td>317</td><td>tags=10%, list=3%, signal=10%</td></tr><tr><td class='lessen'>385</td><td>FARMER_BREAST_CANCER_CLUSTER_6</td><td></td><td>12</td><td>-0.21</td><td>-0.56</td><td>0.962</td><td>1.000</td><td>1.000</td><td>2364</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>386</td><td>SUZUKI_RESPONSE_TO_TSA</td><td></td><td>15</td><td>-0.20</td><td>-0.56</td><td>0.968</td><td>1.000</td><td>1.000</td><td>2105</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>387</td><td>AMIT_SERUM_RESPONSE_20_MCF10A</td><td></td><td>17</td><td>-0.18</td><td>-0.55</td><td>0.990</td><td>1.000</td><td>1.000</td><td>2658</td><td>tags=29%, list=22%, signal=38%</td></tr><tr><td class='lessen'>388</td><td>FINETTI_BREAST_CANCERS_KINOME_GRAY</td><td></td><td>13</td><td>-0.19</td><td>-0.53</td><td>0.957</td><td>1.000</td><td>1.000</td><td>4103</td><td>tags=46%, list=34%, signal=70%</td></tr><tr><td class='lessen'>389</td><td>HOLLEMAN_DAUNORUBICIN_B_ALL_DN</td><td></td><td>10</td><td>-0.21</td><td>-0.53</td><td>0.976</td><td>1.000</td><td>1.000</td><td>9605</td><td>tags=100%, list=79%, signal=480%</td></tr><tr><td class='lessen'>390</td><td>WENDT_COHESIN_TARGETS_UP</td><td></td><td>26</td><td>-0.15</td><td>-0.52</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2021</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>391</td><td>BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX</td><td></td><td>14</td><td>-0.19</td><td>-0.52</td><td>0.993</td><td>1.000</td><td>1.000</td><td>2046</td><td>tags=21%, list=17%, signal=26%</td></tr><tr><td class='lessen'>392</td><td>STARK_HYPPOCAMPUS_22Q11_DELETION_DN</td><td></td><td>16</td><td>-0.17</td><td>-0.49</td><td>0.996</td><td>1.000</td><td>1.000</td><td>10123</td><td>tags=100%, list=83%, signal=604%</td></tr><tr><td class='lessen'>393</td><td>RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN</td><td></td><td>14</td><td>-0.17</td><td>-0.49</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1669</td><td>tags=14%, list=14%, signal=17%</td></tr><tr><td class='lessen'>394</td><td>ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN</td><td></td><td>28</td><td>-0.14</td><td>-0.49</td><td>0.996</td><td>1.000</td><td>1.000</td><td>2129</td><td>tags=14%, list=18%, signal=17%</td></tr><tr><td class='lessen'>395</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C4</td><td></td><td>12</td><td>-0.19</td><td>-0.49</td><td>0.991</td><td>0.998</td><td>1.000</td><td>1658</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>396</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</td><td></td><td>54</td><td>-0.12</td><td>-0.49</td><td>1.000</td><td>0.996</td><td>1.000</td><td>4503</td><td>tags=41%, list=37%, signal=65%</td></tr><tr><td class='lessen'>397</td><td>ZHENG_IL22_SIGNALING_DN</td><td></td><td>32</td><td>-0.13</td><td>-0.45</td><td>0.996</td><td>0.996</td><td>1.000</td><td>3660</td><td>tags=34%, list=30%, signal=49%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_neg_1439146504567.xls'>[plain text format]</a></caption></table></div><br></body></html>